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Diabetes affects 25.8 million Americans. The complications related to this 
growing disease impact public health. One secondary complication of diabetes is changes 
in skin that can contribute to an increased risk for ulceration. The skin of people with 
diabetes has not been characterized over time nor has the skin’s acute response to 
exercise been assessed. The objective of this project was to establish the changes in skin 
properties over time, within different ambient environments, and after acute exercise. 
This objective sought to address the central hypothesis that skin will demonstrate a 
decrease in stiffness and increased elasticity as a result of acute physical activity. Skin 
stiffness, compliance, and thickness measurements of the plantar foot were compared 
across time and environment. Skin stiffness and compliance were also compared before 









1.1 Background and Significance 
 
 Diabetes is a disease that affects 25.8 million Americans.(1) With its growing 
prevalence, the complications of this disease impact public health.(1) One way it does 
this is through changes that occur to the skin and the body’s ability to respond to such 
changes. These changes can contribute to an increased risk of ulceration among those 
with diabetes. (2) The purpose of this chapter is to make a case for examining the impact 
of physical activity on the plantar skin. Multiple steps will be taken to complete this task. 
This chapter will examine the common complications of diabetes that affect the skin and 
will look at the significance of exercise in relation to diabetes. Next, the skin’s response 
to stress will be examined with particular emphasis on the skin in people with diabetes. 
Finally, it will describe the equipment to be utilized along with its supporting research. 
Within this context, missing pieces in the literature will be highlighted so that the need 
for further research will be made evident. In particular, it will clarify the need to 
investigate the acute effects of exercise on plantar skin. 
 To illustrate the factors impacting skin and foot health related to diabetes, the 
broad complications of diabetes will first be described. The mechanisms behind diabetes 
that may lead to these complications will also be presented. Further, the factors and 
behaviors necessary to limit the complications that may occur in the disease process will 
be considered. Such a connection is imperative to paint a broad picture of how to 
minimize diabetes-related health concerns. Moreover, the relationship between the 
diabetes complication and the skin manifestation will be emphasized. Together, these will 
clarify diabetes’ impact on the skin of the plantar foot. 
 Diabetes and poor control of blood glucose are linked with many subsequent 
complications. Broadly, complications of diabetes include both those of the micro- and 
macro-vasculature, which affect the eyes, kidneys, nervous system, circulation, and skin. 
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The mechanism by which these complications occur is not specifically known, but there 
are several possible mechanisms contributing to these problems. 
 The proposed pathways to diabetic complications are related to how the body 
handles hyperglycemia. One such mechanism that has been proposed to lead to chronic 
complications involves the formation of advanced glycosylated end products (AGEs) via 
nonenzymatic glycosylation of intra- and extra-cellular proteins. The AGEs then cause 
proteins to cross-link. Included among these proteins is collagen.(3, 4) Raised serum 
levels of AGEs are associated with individuals with hyperglycemia compared to 
individuals without high blood glucose levels.(5)   
 Other pathways have been proposed to contribute to complications associated 
with diabetes as well. One of these pathways involves an increase in glucose metabolism 
via the sorbitol pathway that generates reactive oxygen species (ROS) and likely leads to 
cellular dysfunction. This pathway, in particular, with its accumulation of sorbitol and 
fructose contributes to changes in the nervous system.(6) Alternatively, hyperglycemia 
may increase the formation of diacylglycerol leading to the activation of protein kinase C, 
which changes the transcription of genes for fibronectin. Finally, hyperglycemia has been 
proposed to act by increasing flux through the hexosamine pathway, which could change 
the function by glycosylation of proteins.(6)  
 Because these mechanisms are tightly associated with hyperglycemia, it is 
necessary to work to prevent these diabetic complications through both improved 
management of blood glucose and with prevention specific to each complication. Good 
blood glucose control has been associated with fewer complications from diabetes. In 
particular, several large-scale studies (Diabetes Control and Complications Trial 
(DCCT)(7-9) and United Kingdom Prospective Diabetes Study (UKPDS)(10) have found 
that those with more tightly controlled blood glucose levels had fewer complications. 
 In agreement with the findings of these studies, the Standards of Medical Care in 
Diabetes’ recommendations call for tight control of blood sugars such that A1C is less 
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than 7% for non-pregnant adults.(11) To control blood glucose, particularly with type 2 
diabetes, a first line of defense is to control blood sugars utilizing diet and exercise.(11) 
When these techniques are being utilized, physical activity is an important component to 
monitor. Exercise, both resistance training and endurance training (stationary bicycle), 
increases the ability of muscle tissue to uptake glucose via the movement of GLUT4 
transporters as well as by increased insulin sensitivity, thereby assisting with blood 
glucose management. (12-15) 
 Despite the positive effects of exercise on diabetes control, areas of high pressure, 
potentially increased during exercise, have been associated with increased risk of skin 
breakdown. Therefore historically, consideration was made to the type of exercise 
encouraged or discouraged based on the diabetes complications that were present. For 
example, for those with diabetes and “severe” peripheral neuropathy (PN), previous 
guidelines for physical activity suggested non-weight-bearing exercise to meet the 
recommendations for 150 minutes of exercise per week.(16) More recently it has been 
shown that with walking exercise, the skin’s risk for breakdown does not seem to 
increase despite the accumulation of stresses.(17-20) Originally, it is likely that this 
weight-bearing concern was reflective of the risk for re-ulceration that can occur with 
return to walking that is not tightly controlled and slowly increased. This issue can still be 
seen with documentation of re-ulceration or ulceration that occurred with exercise that 
was variable rather than exercise that was progressively increased.(19, 21) 
 How does skin respond to the stress of exercise? Generally, tissue that 
experiences a large magnitude of physical stress over a short time or a lesser stress over a 
longer time could develop an ulcer, particularly if other factors contribute to the risk.(22) 
This “stress” includes any pressures that are imposed on the skin including compressive, 
tensile, torsional, and shear forces which may occur while walking or doing other 
activities. While it is clear that off-loading a sore is important during recovery following 
injury, it seems that skin which regularly receives more stress, including standing and 
 4 
walking, is actually more tolerant to stress.(17, 18, 20) This is in agreement with the 
physical stress theory of Mueller and Maluf.(18) Since it was published in 2002, other 
studies have supported the concept.(17-20) Maluf and Mueller found that, in a population 
with diabetes and peripheral neuropathy, those with a history of ulcers were less active, 
taking fewer steps each day and applying less stress to their feet.(20) LeMaster et al. 
found that with an activity intervention, there was no increase in wound rate.(18) 
Previously LeMaster et al. had found that those who spent more time on their feet (7.5 
hours vs. 4.5 hours) were less likely to re-ulcerate.(17) Similarly, Armstrong et al. found 
in their study that people who developed ulcers had a lower mean activity level but a 
higher degree of activity variability. This variability increased further two weeks before 
ulceration.(19) Together these studies point that a chronic response to increased stress is 
an increased tolerance to subsequent stress.  
 However, the study by Armstrong et al. highlights the need to also consider the 
acute effects of exercise. From this study, it is clear that the mode of physical activity or 
exercise prescription (frequency, intensity, duration) is potentially critical. With the 
relationship drawn between increased activity variance and ulceration,(19) one must 
consider how a single bout of physical activity affects the skin on the plantar surface of 
the foot. Further research is important to more thoroughly understand the response of skin 
to physical activity, such as walking, relative to the dosage and timing of the activity. It is 
important to look at these changes not only chronically, as was done with much of the 
previous work,(17-20) but also acutely. 
 When glycemic control is not well maintained, many systemic complications 
related to diabetes can develop. While the complications are systemic, this chapter 
focuses on the complications that affect the skin. These skin complications may 
consequently elevate one’s risk for plantar ulceration and subsequent amputation.(2) The 
changes to skin and its properties are typically described as being multi-factorial. 
Included among these multi-factorial changes are alterations to the nervous tissue and 
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system along with direct structural modifications to collagen and subsequently tissue.(3, 
4, 6) Figure 1.1 summarizes the multi-factorial contribution to a person’s ulcer risk. 
 
 
Figure 1.1 Summary of increased risk for ulceration as related to diabetes mellitus 
 
 First, one of the more prevalent complications is neuropathy, which can include 
changes to the autonomic nervous system (ANS)(6, 23, 24) and somatic nervous 
system.(6, 23-25) ANS complications can involve changes in the skin related to 
temperature control(26) and tissue moisture.(24) Somatic nervous system changes, on the 
other hand, can include changes to motor and sensory nerves including peripheral 
neuropathy. Sensory neuropathy symptoms affect between 30 and 40% of those with 
Type 1 or Type 2 diabetes.(27) Changes associated with neuropathy that may occur 
include decreased moisture to tissue via sweating, increased difficulty with temperature 
regulation, skin cracking and fissures secondary to decreased sweating,(24) changes in 
motor nerve function leading to muscle weakness followed by structural deformity,(25, 
28) and changes to sensory nerves leading to a loss of protective sensation(27, 29, 30) 
and proprioception.(23, 25) All of these changes can lead to a change in gait pattern(31-
36) as well as an increased risk for plantar ulceration.(30) Plantar ulceration may progress 
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to non-traumatic amputation. In fact, more than 60% of non-traumatic amputations occur 
in people who have diabetes.(1) For this reason, it is important to continue looking for 
ways to prevent such complications through improved management of blood glucose as 
well as through better preventive foot care.   
 Neuropathy can be especially problematic when it comes to the skin. When the 
sensory nerves are affected, the result is a decrease in protective sensation. It is well 
documented that if a person is unable to feel the 10 grams of pressure applied with a 5.07 
Semmes Weinstein monofilament, then that person has an increased risk for plantar 
ulceration.(29, 30, 37) Similarly, with damage to the motor nerves, one can see a change 
in the musculature most noticeably in the intrinsic muscles of the feet and the hands. 
Such changes in the muscles may lead to deformities that can increase pressure on certain 
areas of the feet.(38) These increased areas of pressure may increase one’s risk for skin 
breakdown.(39) 
 When computed tomography was utilized to look at changes in the structure of 
the feet in people with diabetes, Robertson et al. found that the mean density of plantar 
muscle under the mid-metatarsals was significantly less in people with diabetes compared 
to matched controls.(28) In the same study, they also found that people with diabetes 
were more likely to maintain foot posture in extension. There were significant differences 
for the extension noted in the first and third toes in people with diabetes compared to 
those without.(28) These changes may all contribute to the increased rate of breakdown 
that is seen among people with diabetes compared to those without the disease. 
 The prevalence of skin lesions is another important factor to consider in people 
with diabetes. A group of 238 people with type 1 diabetes for more than 5 years were 
compared to a group of 122 healthy controls to determine the prevalence of skin lesions 
in people with diabetes. The investigators found that skin problems were much more 
common in the group with diabetes, namely, “icthysosiform skin changes…, 
scleroderma-like skin changes, tinea pedis, and dry scaly palms.” (40) In a more recent 
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study looking at both type 1 and type 2 diabetes, Farshchian et al. (2010) found that 71% 
of their subjects had some skin lesion “associated with DM.”(41) They found that 
infectious lesions were more typical in this population.(41) This group did not look at 
healthy controls along with the group with diabetes, making it difficult to determine 
whether the same skin lesions were typical in a healthy population as well. 
 Skin manifestations that have been related to these diabetes complications include 
alterations in its structural and mechanical properties. Some groups have looked at 
specific effects of diabetes on the mechanism of skin changes. Many of the studies point 
to the advanced glycosylation end products (AGEs) that are produced when glycemic 
control is poor. AGEs have been associated with changes in collagen formation in tissue; 
particularly, more cross-linking has been seen.(3, 4)  Collagen, along with elastin, are 
largely responsible for much of the tensile properties of skin tissue.(42) Diabetes-
associated changes in collagen have been tested utilizing rat models. Oxlund and 
Andreassen applied a load to the tail tendons of rats and measured the speed at which the 
tendons broke. They found that the rats not given aminioguanidine, a substance that 
inhibits the alteration of the properties of collagen associated with diabetes, had tail 
tendons that took longer to break. These increased times likely demonstrate the increased 
cross-linking of proteins seen with diabetes.(43) AGEs have also been found to be more 
prevalent in the skin of people with higher levels of diabetes complications.(44) 
 These structural changes are accompanied by measurable changes in the skin 
properties. Most notably, changes in skin stiffness and thickness can be seen in those with 
diabetes when compared to those without the disease.(4, 45-49) First, changes in skin 
stiffness relative to location and disease severity will be addressed. 
 Multiple investigators have noted that skin stiffness increases in a population with 
diabetes.(45-47) In these studies, skin stiffness was measured by several mechanisms 
including an indentor, a tissue ultrasound palpation system, and indentation associated 
with the use of a MRI.(45-47) In the study by Klaesner et al., the authors report 
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measuring stiffness utilizing an indentor while measuring foot locations with the subject 
in prone. With their indentor, pressure was applied orthogonally while position and force 
were measured simultaneously to give a stiffness value.(45) The increased stiffness they 







) varied between the groups with and without diabetes, heel 
stiffness in people with diabetes did not vary from those without the disease.(45)  
 Similarly, orthogonal force was applied and removed with the tissue ultrasound 
palpation system in the study by Sun et al. In this system, an ultrasound transducer at the 
end of the indentor enabled visual monitoring of compression and decompression of 
plantar tissue. Custom software allowed the calculation of stiffness.(46) These 





heel among the group with diabetes and peripheral neuropathy compared to people 
without diabetes.(46) Also using technology, Gefen et al. used spherical indentation and 
MRI to find stiffness and shear. This group found increased effective shear and elastic 
moduli at the area between the first two metatarsal heads.(47) Together, these studies 
using orthogonal pressure, found increased stiffness in people with diabetes compared to 
those without in some of the plantar locations tested, but not all locations. These findings 
should be considered when making the selection of locations to be tested experimentally.  
 Skin stiffness also varies with the level of diabetes complication. In the study by 
Chao, Zheng, and Cheing (2011), stiffness increased across subjects with diabetes 
compared to those without it.(50) Sun, Cheng, Zheng, et al. (2011) found that neuropathic 
changes were accompanied by increased stiffness of the foot.(46) Other studies have also 
reported increased stiffness in people with diabetes, particularly in those with 
complications.(45, 47) The study by Gefen et al., which used an MRI to look at load and 
deformation, unfortunately compared elderly people to diabetes with normal, young 
subjects.(47) By making such a study design decision, these investigators confounded 
their results such that one cannot dissociate age from disease process so that differences 
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in stiffness cannot be assigned causally to one or the other. Klaesner et al. found that 
those people with diabetes and peripheral neuropathy and other complications were more 
profoundly stiff than those without complications.(45) An earlier study found similar 
results using a different measurement device. The device used, the durometer, was held, 
perpendicularly to the tissue with only the weight of gravity. In this study, the authors 
found that plantar skin tissue hardness was increased with more severe neuropathy. (51) 
 Stiffness in people with diabetes also has been studied relative to compressive 
stresses. Hsu et al. (2009) looked at stiffness of the heel in those with and without 
diabetes. They found that changes related to diabetes may result in a poorer ability to 
cushion at the heel.(52) Similarly, Pai and Ledoux (2010) looked at the mechanical 
compressive properties of skin in people who had diabetes versus those who did not. 
They too found those with diabetes had stiffer tissue and therefore probably had 
increased difficulty dissipating stresses to the skin as well.(49) This study looked at skin 
from cadaveric subjects with the skin removed.(49) Thus, caution should be used 
regarding interpretation of the data because of the possibility of secondary changes to the 
structure of the tissue caused by either removal from the body or by death of the tissue. 
 Other changes to skin also occur in the presence of diabetes. Multiple studies have 
looked at the change in skin thickness as well as a change in soft tissue thickness 
associated with diabetes.(4, 46, 48, 50) Skin thickness findings of these groups varied. 
Chao, Zheng, and Cheing(50) found that, compared to a control group without diabetes, 
people with type 2 diabetes without neuropathic complications had an increased thickness 
of the epidermis. Those with neuropathy and/or ulceration (present or past) had decreased 
epidermal thickness. In a similar study, but involving people with earlier neuropathic 
changes (inability to feel a 4.31 Semmes Weinstein monofilament instead of a 5.07 
monofilament), Sun, Cheng, Zheng, et al. did not find a difference in the soft tissue 
thickness on the plantar foot.(46) Hanna et al. found those with diabetes had increased 
skin thickness in the dermis rather than the epidermis. This group found that, although 
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some with diabetes were described as having “thick skin,” all of the people tested with 
diabetes had skin that was twice as thick as the control subjects.(4) Additionally, the 
morphology of the biopsies was also viewed and those with diabetes were found to have 
“hyalinized and disorganized” collagen with mostly large fibers which differed from the 
controls or those with scleroderma.(4) A valuable point made by this study is that some 
of the changes that can be measured in a population with diabetes cannot outwardly be 
seen as changes to the skin tissue.(4) When Huntley et al. (1990) tried to define a 
relationship between the thickness of skin in those with diabetes and age, they found that 
diabetes type, level of glycosylated hemoglobin (diabetes control), or presence of other 
complications could not be correlated. This group did find that, in those with diabetes, 
skin thickness was increased on the hands and feet, but not on the back.(48) Together, 
these studies show the wide variability of skin thickness in people with diabetes. Despite 
the variability in thickness, it is clear that skin morphology changes in people with 
diabetes. This evident variability makes it obvious that testing needs to be included which 
helps to quantify the extent of neuropathic involvement in those with diabetes. Such 
quantification may help explain differences that may be seen with further investigation. 
 There are certainly other disease and non-disease specific reasons that skin 
changes. There is evidence that the properties of skin, such as thickness, stiffness, 
viscoelasticity, and echogenicity, differ with age,(53, 54) gender,(55) time of day,(56) 
level of hydration,(57-60) and disease.(4) In addition to these causes for differences, skin 
properties have been shown to change with interventions such as cortisone.(61, 62) 
 Skin thickness is typically measured noninvasively using ultrasound (US). US can 
identify thickness of tissue layers and presence of subcutaneous structures. US displays 
the echogenicity of tissue, meaning how much the tissue reflects the ultrasound waves. 
Something with high echogenicity would appear bright white while something with low 
echogenicity would appear darker because of minimal reflection. The level of 
echogenicity helps the investigator determine the thickness of the tissue being measured. 
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In a review study, Waller and Maibach report that whole skin changes throughout the 
lifespan are a bit controversial (2005). (63) They convey that some of the differences 
depend on whether or not tissue has been exposed to the environment.(63) Additionally 
they report a “subepidermal low echogenic band that thickens with age.”(63) Age-related 
skin changes primarily occur early and later in life. (53) According to Escoffier, et al. 
(1989),(53) there is a thickening of skin up until the third decade, but overall, there are 
few changes that happen to skin from age 15 until 65. After 65, the skin reportedly 
thins.(53) Laurent et al. found that there was little difference in skin thickness in the 
subjects they tested who were between the ages of 18 and 70.(64) Similarly, de Rigal, et 
al. (1989) also report that thinner skin is present among the young and the elderly.(54) 
Additionally, there is evidence that skin thickness may increase or decrease with age 
based on the location of the skin.(56) For example, the investigators report that facial skin 
thickens with age while the skin of the forearm thins when measured in the morning.(56) 
 Changes in fluid levels associated with the time of day also seem to impact the 
properties of skin. For instance, Tsukahara et al. found that as the day progressed, the 
tissue thickness increased in the lower extremities but decreased in the upper extremity 
and face.(56) Not only were changes seen with skin thickness, but echogenicity also 
increased as skin thickness decreased.(56) In the same study, elasticity decreased in the 
lower extremities while it increased in the face and the forearm. (56) Seemingly, these 
diurnal changes may be related to the amount and distribution of fluid that is present in 
the limb during the day. This fluid shifts relative to gravity during the day. (56) 
 Similarly, one can see a change in the tissue thickness when an edematous limb 
was compared to an unaffected limb (unpublished data). In a different study looking at 
the effects of altitude on skin, the authors found skin thickness changed depending on 
fluid distribution and related to altitude.(65) To our knowledge, plantar skin was not 
tested in these studies looking at diurnal variations. With this available literature, it seems 
that, when designing a study looking at skin, it would be prudent to measure the skin at 
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similar times of the day to avoid confounding skin property results with natural diurnal 
variation. However, given the locations of skin tested in the previous literature, it would 
also be helpful to look at the plantar skin at different times of the day to add to the body 
of knowledge regarding possible diurnal variation within this particular skin area. 
 A few studies have more directly looked at the level of hydration by studying the 
epidermis. (57-59, 66) While these studies attempted to look at the mechanical properties 
of skin relative to the hydration levels, the investigators used skin that had been hydrated 
via external mechanisms. For example, rather than have the subjects drink appropriate 
amounts of fluids to be considered euhydrated and then test either their urine or blood for 
markers of hydration, the investigators soaked the subjects’ skin in water, (66) applied 
water directly to the skin, (58) or applied moisturizers to the skin,(59) thus secondarily 
hydrating the tissue by minimizing evaporation. Klaus et al., on the other hand, found a 
strong relationship between skin thickness and the amounts of fluid replacement during a 
surgical procedure. (67)  
 Whether the mechanism by which the skin achieves a status of hydration affects 
the mechanical properties is unknown. What is known is that by the mechanisms studied, 
hydration does seem to affect the mechanical properties of tissues.(57-59, 66) 
Specifically, an increase in hydration was accompanied by an increase in the friction 
coefficient. (58, 59) The coefficient of friction is the ratio of the frictional force between 
the instrument and the skin divided by the normal interface force. Increased hydration 
was also accompanied by a change in thickness. (67) When viscoelastic properties of skin 
are viewed in the presence of hydration, Christensen, et al. found that hydration increased 
the amount of hysteresis that occurred with mechanical testing (1977).(57) Jemec, et al. 
in 1990, similarly described this phenomenon.(66) While hydration levels are likely to 
affect skin behavior, hydration level may not be affected by diabetes. (68) But, in people 
with diabetes, Seirafi, et al. found diminished activity of the sebaceous gland resulting in 
a change in sebum content along with lowered skin elasticity in skin regions.(68) Given 
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the possibility of the hydration effects on skin mechanical properties, it is important to 
consider an individual’s level of hydration to see if those levels can be correlated to skin 
properties. The literature does not assess dietary hydration’s effect on skin tissue. 
 Other factors have also been described that influence the response of skin to 
pressure and shear forces. Jagoda et al. (1981) illustrate that, depending on skin color, 
their subjects responded differently to blister prevention techniques. Those with fair skin 
actually developed fewer blisters if using an underlying nylon sock instead of the white 
athletic sock that was more beneficial for those with a darker complexion.(69) Skin 
environment also seems to impact how the skin responds. Whitfield (1932) reported that 
callus is more likely to form in a dry environment whereas a blister is more likely to form 
in a wet environment.(70)  
 Skin has been shown to change in response to certain medical treatments such as 
topical steroid use. One double-blind, controlled study using hydrocortisone cream found 
that some of the thinning of the skin that occurred over six weeks could actually be seen 
in as little as two days. Interestingly, removal of the treatment resulted in a recovery of 
the loss in thickness to 91 to 96% of the original thickness of the skin.(62) These 
measurements were determined using ultrasound techniques. (62) This interventional 
study shows that skin has the capacity to change quickly and acutely.  
 As detailed, research has documented a wide variety of changes in skin and tissue 
properties, but gaps in knowledge still persist. Few studies have considered the natural 
variation of skin properties within the same individual over time or across different 
environments. To our knowledge, no studies have measured the properties of plantar skin 
in an environment similar to the one in which physical activity occurs, the shoe. Given 
these gaps in our knowledge, research is needed to document the stability of skin 
properties over time and within varying environments. This knowledge will then allow 
more informed research into skin and tissue changes that occur after activity and other 
therapeutic interventions.  
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 People with diabetes are prescribed many types of therapeutic interventions 
including physical activity and foot orthotic devices that promote an improved gait 
pattern or alter the loading on aspects of the foot.  The impacts of these interventions on 
skin and skin breakdown must be evaluated.  
 Ultimately, the effects of these interventions on skin and overall health must be 
assessed in a longitudinal manner. Only then can the effectiveness and cost efficiency be 
measured.  However, prior to establishing a long-term approach to testing, we must close 
the existing knowledge gaps about variations and changes in skin properties.  
 The objective of this project is to establish the changes in skin properties over 
time and after acute exercise. This objective seeks to address the central hypothesis that 
skin will demonstrate a decrease in stiffness and increased compliance as a result of a 10-
minute bout of walking. To meet this objective, three Specific Aims are proposed:  
1.2 Specific Aim #1: Validate the instrumentation necessary to characterize 
skin tissue. 
 
 This aim addresses the need for validated tools for assessing plantar skin. We will 
be utilizing three devices to characterize the properties of tissue. Two of these devices 
have not been used on plantar skin so each requires reliability and validity assessment. 
Additionally, we plan to utilize this equipment under two ambient environments, typical 
room condition as well as in high temperature and high humidity (32 degrees C and 66% 
relative humidity). We will evaluate the equipment in the two environments to insure that 
the equipment is not accountable for any variation in measurement. Finally, to assess 
activity, namely walking, we must make sure that we can accurately monitor this activity 
in the presence of altered gait patterns. 
1.3 Specific Aim #2: Characterize the skin tissue of the foot across 
environmental conditions and time. 
 
 This aim will address the need to understand how the skin of people with and 
without diabetes behaves under certain conditions and across different time periods. This 
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will be tested by utilizing US, a myotonometer, and a tissue interrogation device (TID) to 
measure skin in room ambient conditions as well as within an environmental chamber 
mimicking the environment of the foot within a shoe. Multiple measurements will be 
taken within a single day (morning and afternoon testing), within a week, and within a 
month. Because we will look at groups of people with and without diabetes, the study 
will reveal the stability of skin properties but will also expose the differences in 
properties based on the environment and time. The findings will help to inform the timing 
of the methods of future studies. 
1.4 Specific Aim #3: Identify the impact of a 10-minute bout of walking on 
skin tissue. 
 
 This aim will address the hypothesis that skin will change in response to acute 
physical activity imposed on an individual. To accomplish this task, we will utilize 
similar skin property measurements as in Specific Aim #2. Individuals will walk at 
similar speeds on a treadmill. Throughout their activity, we will collect temperature and 
relative humidity data within the shoe as a measure of ANS response. Following activity, 
the skin property measurements will examine how the skin changes with activity. 
 These studies lay important foundational groundwork to extend what is already 
known about diabetes and tissue. First, the validation of instrumentation that is capable of 
measuring skin properties of the plantar foot is crucial for distinguishing changes to the 
plantar skin with different interventional studies. The natural variation of skin relative to 
environment and physical activity is also critical for future interventional studies 
including those further examining various modes, intensities, and durations of exercise. 
Also, this background is necessary to better look at the impact of foot orthotic devices 
and their timing for the prevention of plantar ulceration and subsequent lower extremity 
amputation.  
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2.1 Specific Aim #1: Validate the instrumentation necessary to characterize 
skin tissue 
 
 Many instruments and devices have been used to assess skin properties, including 
xerography/ xeroradiography,(71, 72) ultrasound (US),(48, 50, 52, 56, 73, 74) various 
indentation devices(45, 50, 52) including sub-Metatarsal Pad Elasticity Acquisition 
Instrument (MPEAI),(75) suction cup technique,(76) computed tomography,(28, 77) 
OCT imaging,(78) digital measuring screw,(79) magnetic resonance imaging (MRI) (47) 
biopsies,(80, 81) wavelet transform,(82) Dermalab USB equipment,(83)  infrared 
scanner,(83) and durometer testing.(51) These techniques address different facets of skin 
including thickness and stiffness. Thickness and stiffness, in particular, are addressed 
most commonly using US and indentors, respectively.  
 The measurement of skin thickness using US (48, 50, 52, 56, 62, 67, 73) has been 
found to be reliable and valid.(62, 71, 72) The type of US device that was to be used for 
the upcoming experiments was the Longport Episcan. Kong et al. described this specific 
device as being able to measure thickness with a coefficient of variation of less than 1% 
and a resolution of approximately 0.01 mm for a 5 mm thickness.(84) The Longport has 
also been previously used to measure skin thickness and depth of structure in a variety of 
studies.(85-87)  
 Stiffness, which Sun et al. relate to affecting the tissue’s ability to dissipate 
stress,(46) has largely been measured with a variety of indentors.(45, 50, 52) Indentors 
typically measure the normal force or pressure required to induce displacement. This 
orthogonal measurement reflects the combined stiffness of all tissues under the indentor. 
In addition to measuring the normal force applied to skin and the tissue’s response to this 
force, the skin also responds to a traction force across its surface that occurs with 
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movement. The tissue’s response to this force can be measured using a tissue 
interrogation device (TID) developed at the Georgia Institute of Technology and McGill 
University. This prototype tool needed to be validated prior to use on the plantar skin. 
 The purpose of this aim was to address the need for validated tools for assessing 
plantar skin properties. Equipment was to be utilized that had not been used on the 
plantar surface of the foot or in a population with altered gait. For this reason, it was 
important that the equipment used to monitor physical activity as well as the equipment 
used to examine any changes in the stiffness of skin on the plantar foot be validated. With 
the resultant validation, one could be reasonably sure that changes measured 
experimentally were related to actual changes in the skin rather than measurement error 
associated with a device. 
 This specific aim was accomplished through several experiments. First, a valid 
mechanism was needed to measure physical activity in a group of people who may have 
altered gait patterns. This component was necessary so that physical activity could be 
quantified using step count, regardless of the speed at which an individual walked. The 
StepWatch activity-monitoring device was intended for this purpose. Thus, the 
StepWatch activity-monitoring device was validated. Next, testing elastomeric phantoms 
with known stiffness checked the reliability of the Tissue Interrogation Device (TID v1). 
During experimentation, a second iteration of the TID (TID v2) was completed. 
Therefore, the TID v2 was also checked for reliability. Finally, the myotonometer, an 
indentor device, was tested for its consistency between typical room temperature and 
warm, humid environments (Environmental Chamber (EC)). Together, validation of this 
equipment enabled the remaining specific aims to be addressed.  
2.2 StepWatch Validation: 
 
 The StepWatch is a device designed to measure activity levels. It has been used 
and/or validated across many populations including people who have experienced spinal 
cord injury,(88, 89) stroke,(90-92) and amputation(93). It has also been used among the 
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elderly(94-96) and those with diseases such as diabetes(20, 97, 98). While these studies 
reported that some of the participants used assistive devices, the StepWatch had not been 
specifically validated on a population who used assistive devices. Given that people with 
diabetes often experience a change in gait pattern related to their disease process(31-36) 
and sometimes need an assistive device, it was necessary to perform a validation study to 
enable use of the StepWatch in people with diabetes who may use an assistive device. 
This study was completed and has been published. It can be read in its entirety in 
Appendix A.(99) 
2.3 Tissue Interrogation Device (TID) Validation: 
 
 Stiffness of skin, and the plantar skin in particular, has been measured in previous 
studies.(45-47, 50) The mechanism by which the stiffness of skin has traditionally been 
calculated utilizes indentor devices.(45, 50, 52) Stiffness is generally defined as the 
resistance to deflection or deformation. Indentor devices quantify stiffness by applying an 
orthogonal force to the surface of the skin and measuring the amount of skin 
displacement. When indentors are used in vivo, the measured tissue stiffness is reflective 
of the combination of skin and the subcutaneous tissues. Plantar skin stiffness as 
measured by an indentor mimics the normal loading on skin during stance.  
However, people move. During the gait cycle, the forefoot moves into extension 
as a person moves from mid-stance to push-off. This movement creates a stretching of 
the skin, which is resisted by tensile forces. Characterizing this type of skin stiffness is 
more appropriately measured by applying tangential forces on the skin. The measurement 
of tangential stiffness would be valuable because it would provide a more complete 
picture of the foot’s stiffness, and by extension, its risk for breakdown. While the 
Cutometer® may be able to address measuring this type of stiffness as it looks at 
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different depths of the skin, depending on the size of the probe,(100) the contours of the 
foot and size of the regions of interest would make use of this device difficult. 
The TID (Figure 2.1a and b), developed at Georgia Tech and McGill University, 
was designed to measure localized tangential stiffness. Briefly, the device contacts the 
skin at two points with a small tweezers-like probe and applies tangential force to the 
tissue. Piezoelectric benders drive these contact points laterally with a gentle traction 
force to the skin at a frequency of five hertz (Hz). The device measures both force and 
displacement and provides outputs of skin stiffness and viscosity. With the traction force, 
the measure of stiffness focuses on the more superficial tissues compared to the devices 
that apply a strictly normal, compressive load.  Preliminary testing demonstrated that the 
device was able to measure differences between the skin at different anatomical sites. 
(Wang et al, 2006).(101) Each trial with this device lasted a total of ten seconds. A 
normal force was applied with the device to the skin to provide adequate friction to load 
the skin in traction. A constant force spring, aligned with the plastic housing, decreased 
variation in the normal force applied to the skin. The force used to maintain the TID 
positioning was limited to approximately 1.5 N. To eliminate the risk of electric shock 
and to prevent slipping, two, textured delrin boots were adhered to the tips of the 
piezoelectric benders.  
Validation of this prototype instrumentation was critical to ensure the reliability 
of the TID for measuring the stiffness and viscosity of the plantar skin. Also, this 
reliability was essential to help determine how many TID measurements were needed for 
accuracy in future experiments. During the course of the entire project, the next 
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generation of TID was completed, resulting in the need for additional reliability tests. The 
two separate sets of TID prototype reliability follow. 
2.3.1 TID v1 Prototype Reliability: 
First, the TID v1 (Figure 2.1) was tested using elastomeric phantoms of a known 
stiffness. The testing utilized both a mechanical jig (Figure 2.2) and a handheld technique 
(Figure 2.3). The testing demonstrated the ability of the TID v1 to distinguish surfaces of 
varying stiffnesses. It was also intended to expose any differences between the use of a 
jig, which maintained consistent positioning, and the handheld technique. Following the 
initial phantom testing, the TID v1 was also tested in typical room temperatures as well 
as a warm, humid environment. This environmental comparison testing was designed to 
ensure consistency in device output between environments. Following all of the phantom 









a. Anterior view 
 
b. Posterior view 










b. Side view  




Fig. 2.3 Handheld technique 
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2.3.1.1 Methods 
Samples:  Elastomeric phantoms made of Dragon Skin FX-Pro ® (Smooth-On, Inc., 
Easton, PA), a silicone rubber that was combined with various amounts of thinner to 
make the substance more elastic. The phantoms used were made with 30% thinner and 
80% thinner. Stiffness of the elastomeric phantom decreased with the addition of a larger 
percentage of thinner. Therefore, the phantom with 30% thinner was relatively stiffer 
than the phantom containing 80% thinner. The phantoms were selected to bracket the 
ranges of skin properties so that the reliability of the TID v1 device for testing skin across 
its surface could be determined. After fabrication, the density and Young’s modulus of 




Table 2.1. Description of phantoms 
 Young’s modulus (kPa) Density (kg/m
3
) 
30% phantom (Stiffer) 9.55 990 




Equipment: The TID v1 prototype characterized stiffness in N/m and viscosity in Ns/m
2
. 
The TID v1 was mounted to a jig that enabled precise height adjustment using a precision 
screw (Figure 2.2). This jig enabled a consistent normal force of 1.5 N to be applied to 
the phantom for measurement. 
Environment: Initial testing for reliability was performed in typical room temperature 
conditions using both handheld and jig techniques. The typical room conditions ranged 
from approximately 20 to 24 degrees Celsius and 35-50% relative humidity. The device 
was also tested in an environmental chamber (EC) set to 32 degrees Celsius and 66% 
relative humidity. 
Protocol: For repeatability testing, TID v1 measurements were taken approximately 15 
times per phantom, and technique. Measurement sessions were repeated with each 
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session considered as independent measurements with respect to data acquisition. Finally, 
to compare environments, the handheld technique was used in each environment over 
two measurement sessions.  
 For each trial, the TID v1 was first allowed to acclimate to the testing 
environment for at least 10 minutes. Elastomeric phantoms were maintained in the testing 
room environment for testing completed under typical room conditions. In the case of EC 
conditions, the phantoms were stored in the typical room environment until TID v1 
testing was imminent. This procedure limited the effects that temperature and relative 
humidity had on the phantoms. Approximately 15 measurements were taken using the 
TID v1 per phantom for all trial sessions. Testing procedures for loading the elastomeric 
phantoms were consistent across trials and proceeded as follows. First, TID v1 
measurements were performed in an unloaded position. Then, measurements were taken 
with the TID v1 applying 1.5 N of force to the phantom. The TID v1’s benders were 
programmed to oscillate at five Hz. Measurements were taken for five seconds of 




 Performing this experiment in two environments enabled comparison of the 
effects of these environments on the equipment. If the environments had an effect, the 
interaction between the equipment and the environment would potentially confound the 
results. Such a situation would necessitate the development of a mechanism to account 
for any differences that were noted. This procedure minimized the risk that the equipment 
would be a confounding factor for the study. 
Data Analysis: Independent sample t-tests were utilized to compare means for stiffness 
between the two techniques for testing elastomeric phantoms. This comparison was 
intended to expose any effects that the lowering technique had on the accuracy of 
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measurement. Additionally, independent sample t-tests were utilized to compare stiffness 
means between the 30% thinner (stiffer) and 80% thinner (softer) phantoms. This 
comparison determined if the TID v1 was able to detect differences between phantoms of 
different densities. Similarly, independent sample t-tests were used to compare means of 
stiffness measured within each environment (typical room conditions versus EC) to 
expose any effects that the environment had on the device. Descriptive statistics were 
used to report the findings of all of the techniques. Coefficients of variation were utilized 
to demonstrate the variability of the data. Finally, intra-class coefficients were used to 
demonstrate reliability using measurements taken during two independent measurement 
sessions. 
2.3.1.2 Results 
 Independent sample t-tests found no differences in stiffness measured using the 
two techniques (stiffer phantom, p=0.660 with equal variance not assumed; softer 
phantom, p=0.125 with equal variance assumed). When viscosity was compared between 
techniques, again there was no difference (stiffer phantom, p=0.622 with equal variance 
assumed; softer phantom, p=0.311 with equal variance assumed). Independent sample t-
tests also demonstrated that the TID v1, regardless of technique, was able to differentiate 
between the stiffer and softer elastomeric phantoms (p=0.000 with equal variances 
assumed in all cases). The precision of the instrument to find the true mean was described 
using the 95% confidence intervals (Tables 2.2 and 2.3). For stiffness, these intervals 
represented a precision of instrument measurement that was within 10% of the mean 
stiffness. The intra-class coefficient for the stiffness measurements taken in two 
measurement handheld sessions within typical room conditions was 0.982. The viscosity 
data for this device demonstrated large variations as can be seen in the coefficients of 
variation (CVs), which were between 45 and 82% (Table 2.3). The intra-class coefficient 
for the viscosity measurements taken from the same sessions as the above stiffness 
measurements was 0.610. 
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 When the device was tested within different environments, the results were 
similar. Two sessions were completed on different days and combined into one dataset. 
In the typical room environment, a total of 54 trials was performed with 27 trials for both 
the stiffer and softer phantoms. Fifty-three trials were performed within the EC with 28 
trials for the stiffer phantom and 25 for the softer phantom. (Table 2.4) Again, 
independent sample t-tests confirmed no differences in stiffness values between the two 
environments (stiffer phantom, p=0.775 with equal variances assumed; softer phantom, 
p=0.354 with equal variances assumed). The 95% CI of the handheld measurement 
sessions taken when comparing typical room and EC conditions represents 10.3% or less 
of mean stiffness of the same trials. Several trials during the mechanical lowering were 
lost yielding differences between the number of trials for the stiffer and softer phantom. 
 
Table 2.2. Stiffness measurements for Mechanical jig vs. Handheld techniques. 
StDev=Standard Deviation; CI=Confidence Interval; CV=coefficient of variation; 
SEM=standard error of the mean 
 Phantom N Mean StDev Min Max CV 
(%)  




Stiffer 16 258.8  10.39 241.8 288.3 4.02 2.6 253.69, 
263.87 
Softer 13 155.6  14.69 132.0 185.4 9.44 4.07 147.65, 
163.62 
Handheld  Stiffer 28 261.0  22.42 229.4 303.7 8.59 4.24 252.68, 
269.28 








Table 2.3. Viscosity measurement for Mechanical jig and Handheld techniques. 
StDev=Standard Deviation; CI=Confidence Interval; CV=coefficient of variation; 
SEM=standard error of the mean 







Stiffer  13 -1.693  0.88  -3.046 -0.434 52.0 0.22 -2.13,   
-1.26 




Stiffer  28 -1.825  0.83  -3.617 0.451  45.3 0.16 -2.13,   
-1.52 





Table 2.4. Stiffness values taken under typical room conditions versus EC with the 
handheld technique. StDev=Standard Deviation; CI=Confidence Interval; CV=coefficient 
of variation; SEM=standard error of the mean 






Stiffer 27 247.44  24.74 200.00 288.24 10.00 4.76 238.11, 
256.77 
Softer 27 140.52  18.57 107.97 174.18 13.21 3.57 133.52, 
147.52 
EC Stiffer 28 245.21  30.36 209.88 334.89 12.38 6.07 233.31, 
257.11 






 The results indicated that the TID v1 demonstrated high reliability in 
measurements taken on two different elastomeric phantoms, under different ambient 
conditions (room versus EC) and using different techniques (handheld versus jig). These 
findings enabled several subsequent decisions to be made about using the TID v1 for 
measurement of plantar tissues. 
 The ability of the TID v1 to identify differences in stiffness in a reliable manner 
provided a realistic expectation that the device could be utilized effectively to measure 
stiffness at several locations on the plantar foot. Because there was no statistically 
significant difference between jig and handheld techniques, a decision was made to 
utilize the handheld technique to collect the stiffness data on the plantar foot. It was also 
determined that the data could be trusted to be accurate whether measurements were 
taken within the EC or under typical room conditions. Finally, high correlation of 
stiffness measurements between the sessions (r=0.982) offered assurance that the 
handheld technique could be utilized to compare stiffness across different measurement 
sessions.  
 Viscosity measurements showed wide variability, leading to the decision not to 
utilize the TID v1 for viscosity measurements in the study of plantar tissue.  
  
2.3.2 TID v2 Reliability: 
 Deficits in TID v1 motivated an iterative process to develop an improved device. 
This next generation of the TID (TID v2) (Figure 2.4) was completed prior to the 
initiation of Specific Aim #3. Changes were made to the electronics and improved 
fabrication techniques. These changes resulted in a better signal-to-noise ratio of the 
acquired data and a more reliable operation. Because of these changes and improvements, 
the TID v2 device also needed to undergo reliability testing. This testing again compared 
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two elastomeric phantoms (Table 2.1), two measurement techniques (handheld and 
mechanical jig), and two environmental conditions. Finally, the multiple measurement 
sessions were utilized to characterize how the TID v2 measured stiffness and viscosity.  
2.3.2.1 Methods 
Samples: Elastomeric phantoms, like those used for the TID v1 prototype testing, were 
used to test the reliability of the TID v2. A stiffer phantom (30% thinner) and a softer 
phantom (80% thinner) were again utilized for testing stiffness and viscosity across the 
surface of the phantoms. 
Equipment: The TID v2 was utilized to gather the stiffness and viscosity data of the 
elastomeric phantoms. The TID v2 was mounted to a rig utilizing a precision screw that 
permitted precise height control to apply a 1.5 N orthogonal force to the phantom in 
advance of applying the tangential forces. 
Environment: Testing was performed within typical room conditions (between 20 and 24 
degrees Celsius and 35-50% relative humidity) and within an EC set to 32 degrees 
Celsius and 66% relative humidity. 
Protocol: Initial testing was performed to assess the differences between the mechanical 
jig and handheld measurement techniques. Subsequent testing utilized the mechanical jig 
technique to allow the most precise control of the forces employed. Testing procedures 
for loading the elastomeric phantoms were consistent across trials and proceeded as 
follows. First, measurements were performed in an unloaded position. Then, orthogonal 
pressure by the device to the phantom was applied to 1.5 N during the measurement 
period to maintain the position of the device. The probe moved at a frequency of five Hz. 
Measurements were taken for five seconds of oscillations each, both unloaded and 
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loaded. The device outputs were stiffness (N/m) and viscosity (Ns/m
2
). Test sessions 
were considered to be independent. 
 Testing was performed in sessions of 22 trials each. Sessions were conducted in 
the lab at the Center for Assistive Technology and Environmental Access (CATEA), the 
exercise physiology laboratory (EPL), and in the EC within the EPL. For measurement 
technique comparisons, three sessions were performed on each elastomeric phantom 
(30% thinner (stiffer) and 80% thinner (softer)) using both techniques. Next, to assess 
differences in environmental conditions, test sessions were repeated under typical room 
conditions and within the EC. Finally, the first two sessions for each phantom measured 
in each location (CATEA, EPL, and EC) were utilized to measure day-to-day reliability 
for the TID v2 device. 
Data Analysis: Comparison of means testing was performed using independent sample t-
tests. These were employed for the following comparisons: measurement techniques, 
phantom stiffness, and consistency of measurement within different environmental 
conditions. All independent sample t-tests were performed separately for stiffness and 
viscosity outputs. For reliability, descriptive statistics were used to describe findings of 
the techniques. Coefficients of variation were used to describe variability of data. 
Additionally, intra-class correlation coefficients were used to demonstrate day-to-day 
reliability.  
 Finally, statistical analysis was used to determine how many trials should be used 
experimentally when measuring plantar tissues. This analysis assessed using three and 
five repeated measures using the softer phantom data collected with the handheld 
technique because of its greater variance. Sixty-four points of stiffness and viscosity were 
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used in the analysis. A set of five data points was randomly identified using 
www.random.org. This random selection was chosen because no ordering effect was 
noted for trials within a session. This selection process was repeated five times. After 
each randomization, the first three points were placed in the “3 Trials” dataset and the 
five points were placed into the “5 Trials” dataset.  There were a total of five sets of both 
“3 Trials” and “5 Trials” data that were representative of the initial 64-point dataset. The 
mean and median were calculated and compared to the overall mean of the 64 points. 
2.3.2.2 Results 
Differentiation of measurement techniques: Using an independent sample t-test to 
compare means for the same phantoms using different lowering techniques, there was no 
difference between the two techniques when measuring the stiffness (p=0.672 with equal 
variances not assumed) or viscosity (p=0.845 with equal variances assumed) of the stiffer 
elastomeric phantom (30% thinner). However, when the two techniques were compared 
when testing the stiffness of the softer phantom (80% thinner), there was a difference 
(p=0.013 with equal variances not assumed) between the two. The viscosity of the 80% 
thinner phantom did not show a difference between the techniques (p=0.507 with equal 
variances assumed).  
 These testing sessions were further examined for measurement reliability by 
calculating CVs for both stiffness and viscosity. CVs for stiffness measurements of 
individual sessions utilizing the jig were less than 1% for both phantoms.  Aggregating 
data from all sessions slightly raised the CVs but they remained less than 2%. The CVs 
for individual sessions using the handheld technique were also low, with a range of 2.1% 
to 5.3%. Aggregate values for stiffness CVs using the handheld technique were 2.9% for 
the stiffer phantom and 5.1% for the softer phantom (Tables 2.5 and 2.6). CVs for 
viscosity measurements utilizing the mechanical jig for individual sessions were less than 
8% as were the aggregated values (Table 2.7). For individual sessions, the handheld 
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technique exhibited CVs that ranged from 4.6% to 10.3%. Aggregate values for handheld 
viscosity CVs were less than 10% (Table 2.8). In general, variations in both stiffness and 
viscosity were greater with the softer material and when using the handheld measurement 
technique.  The precision of the instrument to find the true mean for both stiffness and 
viscosity can be seen with the 95% confidence intervals (CI) also listed in the same 
Tables. The 95% CI using the mechanically jig sessions represented 1.5% or less of the 
mean stiffness values and 6.5% or less of the mean viscosity values. 
Differentiation of phantom densities: Using independent sample t-tests to compare the 
overall means of both measurement techniques together as well as each separately, the 
device was able to detect differences in both stiffness and viscosity between the 
phantoms  (p=0.000 with equal variances not assumed for stiffness and equal variances 
assumed for viscosity). 
Differentiation of environmental conditions: When the device was tested within different 
environments, results were dependent on material and situation (Tables 2.9 and 2.10). 
Again, independent sample t-tests were used to confirm any differences between the two 
environments. With the softer phantom (80% thinner), stiffness had p=0.054 (equal 
variances assumed) whereas viscosity had p=0.058 (equal variances not assumed) so no 
differences were present. For the stiffer phantom (30% thinner), on the other hand, an 
event during the testing affected the outcome. During the first session of measuring the 
stiffer phantoms in the EC, the Delrin boot on one of the piezoelectric benders broke 
requiring its reattachment. When all the sessions’ trials were combined, no differences in 
stiffness (p=0.233 with equal variances not assumed) or viscosity (p=0.792 with equal 
variances assumed) were found. But, if the EC trials prior to the break were thrown out, 
there was a difference between environmental conditions for both stiffness (p=0.042 with 
equal variances not assumed) and viscosity (p=0.025 assuming equal variances).  
Day-to-Day Reliability: Using intra-class correlation coefficients, the day-to-day 
reliability for stiffness was moderate to high as it varied between 0.802 for all the 
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conditions measured in the EPL (room and EC environments) and 0.932 for all of the 
typical room conditions. Also, viscosity values varied between 0.996 (room and EC in the 
EPL) and 0.855 (for all typical room conditions) (Tables 2.11 and 2.12). 
Trial Number: When the differences between the mean and median of the random data 
sets and that of the entire dataset (Table 2.13) are reviewed, the “3 Trials” and “5 Trials” 
reveal equivalent results. Stiffness values of the randomized sets were within 3.5% of the 
overall mean of 22 trials, whereas viscosity values were within 9%. These values are 
consistent with the CVs that were found within the sessions as well as the aggregate 
































Table 2.5 Stiffness Measurements with Mechanical jig 
N=number of trials; StDev=Standard Deviation; Min=minimum; Max=maximum; 
CV=coefficient of variation; SEM=standard error of the mean; Agg=aggregate; CI=95% 
Confidence interval 
Phantom Session N Mean StDev Min Max CV 
(%) 
SEM CI 
Stiffer 1 22 547.1 2.44 541.26 550.38 0.45 0.520 546.08, 
548.12 
2 22 548.4 2.25 543.14 551.34 0.41 0.480 547.49, 
549.37  
3 22 535.7 2.63 527.11 539.06 0.49 0.562 534.58, 
536.78 
Agg 66 543.7 6.25 527.11 551.34 1.15 0.769 542.23, 
545.25 
Softer 1 22 477.9 4.30 464.38 487.53 0.90 0.917  476.1, 
479.71 
2 22 486.0 8.79 462.98 498.30 1.81 1.875 482.33, 
489.67 
3 22 459.1 6.25 444.76 468.16 1.36 1.332 456.47, 
461.69 














Table 2.6 Stiffness Measurements with Handheld Lowering 
N=number of trials; StDev=Standard Deviation; Min=minimum; Max=maximum; 
CV=coefficient of variation; SEM=standard error of the mean; Agg=aggregate; CI=95% 
Confidence interval 
Phantom Session N Mean StDev Min Max CV 
(%) 
SEM CI 
Stiffer 1 21 552.9 11.94 516.59 567.44 2.16 2.606 547.83, 
558.05 
2 22 536.1 16.5 481.77 552.58 3.08 3.518 529.22, 
543.00  
3 22 540.0 12.85 516.41 561.9 2.38 2.740 534.61, 
545.35  
Agg 65 542.9 15.49 481.77 567.44 2.85  1.921  539.09, 
546.63 
Softer 1 20 481.7 25.45 424.63 514.26 5.28  5.691 470.52, 
492.82 
2 22 451.7 17.2 425.99 480.85 3.81  3.667  444.48, 
458.86 
3 22 466.0 18.46 439.03 505.14 3.96  3.936 458.33, 
473.75 














Table 2.7. Viscosity Measurements with Mechanical jig 
N=number of trials; StDev=Standard Deviation; Min=minimum; Max=maximum; 
CV=coefficient of variation; SEM=standard error of the mean; Agg=aggregate; CI=95% 
Confidence interval 
Phantom Session N Mean StDev Min Max CV 
(%) 
SEM CI 
Stiffer 1 22 5.782 0.348 5.415 6.751 6.02 0.0742 5.637, 5.927  
2 22 5.616 0.308 4.813 6.580 5.48 0.0656 5.487, 5.745 
3 22 5.588 0.193 5.214 5.999 3.46 0.0412  5.507,5.669 
Agg 66 5.662 0.299 4.813 6.751 1.15 0.0368 5.590, 5.734 
Softer 1 22 4.992 0.320 4.141 5.552 6.41 0.0682 4.858, 5.126 
2 22 5.164 0.402 4.460 6.080 7.79 0.0858 4.996, 5.332 
3 22 4.923 0.364 4.440 5.834 7.39 0.0776 4.771, 5.075 



























Table 2.8 Viscosity Measurements with Handheld Lowering 
N=number of trials; StDev=Standard Deviation; Min=minimum; Max=maximum; 
CV=coefficient of variation; SEM=standard error of the mean; Agg=aggregate; CI=95% 
Confidence interval 
Phantom Session N Mean StDev Min Max CV 
(%) 
SEM CI 
Stiffer 1 21 5.804 0.471 5.081 6.853 8.12 0.1028 5.603, 
6.005 
2 22 5.515 0.311 4.843 6.308 5.63 0.0662 5.385, 
6.645 
3 22 5.709 0.349 4.887 6.274 6.12 0.0745 5.563, 
5.855 
Agg 65 5.674 0.395 4.843 6.853 6.95 0.0489 5.578, 
5.770 
Softer 1 20 5.19 0.535 4.606 6.545 10.31 0.1196 4.956, 
5.424 
2 22 4.977 0.481 4.348 6.303 9.66 0.1026  4.776, 
5.178 
3 22 4.787 0.221 4.446 5.214 4.61 0.0471 4.695, 
4.880 













Table 2.9. Ambient versus EC (32º C, 66% relative humidity) descriptive data for 
stiffness (Aggregate from 2 sessions each). StDev=Standard Deviation; CI=Confidence 
Interval; CV=coefficient of variation; SEM=standard error of the mean 
Condition Phantom N Mean StDev Min Max CV 
(%) 
SEM 95% CI 
Ambient Stiffer 44 542.11 10.88  514.7 561.0  2.0 1.64 538.90, 
545.33  
Softer 44 467.33 21.17  433.0 517.8  4.5 3.19 461.08, 
473.59 
EC Stiffer 44 540.18  6.30 531.7 545.8  0.7 0.56 537.72, 
539.92 





Table 2.10. Ambient versus EC (32º C, 66% relative humidity) descriptive data for 
viscosity (Aggregate from two sessions each). StDev=Standard Deviation; 
CI=Confidence Interval; CV=coefficient of variation; SEM=standard error of the mean 
 
Condition Phantom N Mean  StDev Min Max CV SEM 95% CI 
Ambient Stiffer 44 5.620  0.219 5.131 5.985  0.039 0.0330 5.555, 
5.684 
Softer 44 5.057  0.416 4.349 6.164  0.082 0.0628 4.934, 
5.180 
EC Stiffer 44 5.749  0.304 5.292 6.771 0.055 0.0473 5.625, 
5.810 






Table 2.11. Stiffness reliability for combined stiffer and softer phantoms. 
 Intra-class r 
All locations/sessions/environments 0.850 
Lab room and EC 0.802 





Table 2.12. Viscosity reliability for combined stiffer and softer phantoms. 
 Intra-class r 
All locations/sessions/environments 0.919 
Lab room and EC 0.996 





Table 2.13 Determination of trial number 
Stiffness 
3 Trials A B C D E 
mean 0.51% -0.03% -1.53% -0.77% 2.38% 
median -3.23% 1.09% -3.45% -1.47% 3.31% 
5 Trials      
mean 0.69% 0.54% 0.99% -2.09% 2.52% 
median 0.80% 1.09% 0.80% -1.47% 3.31% 
      
Viscosity 
3 Trials A B C D E 
mean -8.62% 1.05% -0.41% 1.98% 2.00% 
median -7.47% -5.80% -0.63% -1.05% 4.74% 
5 Trials      
mean -7.11% 0.66% -3.40% -1.20% 4.39% 
median -7.47% -2.84% -5.99% -3.46% 4.74% 
 
 
2.3.2.3 Discussion  
 The TID v2 was tested for reliability using two elastomeric phantom densities 
(30% thinner and 80% thinner). Statistically significant differences were noted between 
the mechanical and handheld lowering techniques. Statistically significant differences 
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were also noted when comparing ambient versus EC environment testing, depending on 
which values were utilized. These findings resulted in several decisions. 
 First, it was determined that using the mechanical jig resulted in smaller CVs and 
thus measurements that were more repeatable within a testing session. Because of this 
finding, the subsequent use of the mechanical jig was chosen to improve the precision of 
measurement. No further handheld measurements were conducted with this device. This 
finding also suggested that development of a mechanism to mechanically control the 
lowering of the device for future experimental usage was important. 
 Differences were found between the environmental condition measurements only 
in the case of the stiffer phantom when the trials from a more similar device were thrown 
out. This “more similar device” was described as such because the boot location was 
identical between the trials until the boot detached. With such an equipment failure, 
repair was unlikely to have resulted in an exactly identical placement of the boot as was 
previously employed. Despite this, to minimize the effects of the heat and humidity on 
the device, it was planned that the actual device be maintained outside of the chamber 
during testing. The EC comes equipped with a hole in the wall through which the probe 
can be passed for use in the chamber. While it is not being used, the probe can rest within 
the wall at a temperature closer to the ambient conditions of the laboratory. However, 
when one considers the expectation that all experimentation associated with Specific Aim 
3 will take place in the EC, then, it is more important to look at the reliability within a 
single condition. 
 The TID v2 demonstrated that it was able to detect differences in stiffness where 
differences existed. With this determination, it can be expected that this device has 
appropriate precision and reliability so that differences in stiffness and viscosity can be 
detected on the skin of the plantar foot. Based on the dataset from the three sessions of 22 
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trials, especially looking at the CV and standard error of the mean, the measurement 
accuracy was expected to be ± 5% for stiffness and ± 10% for viscosity. 
 It should be noted that with many of the independent sample t-tests equal variance 
could not be assumed. Additionally, there was a sizable variance between ICC values, 
depending on what sessions were combined. It is clear that the sessions that occurred 
under more similar conditions also had higher correlations and smaller variance. With the 
high precision of this instrument, it is likely that its immediate environment, to some 
degree, affects the TID v2. For instance, some trials, particularly at CATEA had various 
amounts of air disturbance present during testing. This included large outside doors 
opening and closing as well as air conditioning coming on or turning off. Such changes in 
the immediate airflow, could have affected the consistency of the measures. With the 
possibility that variances in the environment, including differences in temperature and 
relative humidity, affect precision, it is important that one considers the location where 
testing is completed. It is suggested that testing is not performed directly under air vents 
and it is encouraged to test in a consistent environment when comparisons are to be 
made. 
 The results for the sampling guidelines for three or five trial sessions are 
consistent with the mean and median results from larger samplings. This result suggests 
that either a sampling of three measures or a sampling of five measures would be equally 
appropriate to perform.  
2.4 Myotonometer Reliability in Typical Room versus Environmental Chamber 
Conditions: 
 
 Stress to feet occurs with both static and dynamic positioning. For this reason, it is 
still important to measure stiffness in a normal direction. Stiffness measured by applying 
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a normal force, often with an indentor, is the traditional way to evaluate a tissue’s 
response to stress. As is typical of indentors, the myotonometer (Neurogenic 
Technologies Inc.) can be used to measure compliance when a given force is applied 
orthogonally. While this device was initially designed to measure muscle tone,(103) it 
was previously used on the skin of the buttock in patients with spinal cord injury.(104) 
Previous measurement had been performed in a typical room temperature environment. 
Because multiple environmental conditions were anticipated, it was important to assess 
the ability of the device to be consistent across conditions, including one that was warm 
and humid. 
2.4.1 Methods 
“Samples”: Elastomeric phantoms, like those used for the testing of both TIDs, were 
used to test the reliability of the myotonometer. A stiffer phantom (30% thinner) and a 
softer phantom (80% thinner) were utilized for testing stiffness. 
Equipment: The myotonometer (Neurogenic Technologies Inc.) was utilized to measure 
the compliance (displacement/force) of the elastomeric phantoms with a given force. The 
force that was provided was 1.5 kg. The myotonometer measured displacement at the 
following force application points (kg): 0.25, 0.43, 0.61, 0.79, 0.96, 1.14, 1.32, and 1.5. 
The manufacturer selected these forces to allow for an adequate range of force-
displacement measurements. 
Environment: Testing was performed in a typical room temperature condition as well as 
in a warm, humid condition within an EC. The room condition was between 20 and 24 
degrees Celsius and 35-50% relative humidity. For environmental comparison testing, the 
EC was set to 32 degrees Celsius and 66% relative humidity. 
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Protocol:  For each session, the myotonometer was first allowed to acclimate to the 
testing environment for at least 10 minutes. The elastomeric phantoms were maintained 
in the room environment for testing completed under typical room conditions. In the case 
of the EC condition, the phantoms were maintained in the typical room condition until 
testing was imminent. This procedure limited the effects that the temperature and relative 
humidity had on the phantoms. Performing this experiment in two environments allowed 
for analysis to compare environmental effects on the equipment. 
 Each trial consisted of eight repetitions of an orthogonal force of 1.5 kg being 
applied to the phantom. Each repetition took between one and two seconds. The 
myotonometer software combined the repetitions for a single output per trial. Six trials 
were performed for each phantom in each condition. 
Data Analysis: Independent sample t-tests were utilized to compare the displacement 
means of the stiffer and the softer phantoms both together and separately between the two 
environments. Comparisons were made at each of the eight points of force where 
measurements were taken (0.25, 0.43, 0.61, 0.79, 0.96, 1.14, 1.32, and 1.5 kg).  
2.4.2 Results 
 When the stiffer and softer phantoms were compared together for the separate 
environmental conditions, there were no differences (p values ranged from 0.641 to 
0.991). When the stiffer phantom was compared separately between the two conditions, 
again no differences were found between the typical room and EC conditions (p values 
ranged from 0.130 to 0.892). In each of these cases, there was no violation of 
homogeneity of variances. Finally, when the softer phantom was compared separately 
between the two conditions, a difference was found only at the initial displacement point 
(0.25 kg) with a p value of 0.043. Additionally, violations of homogeneity of variance 




 When the myotonometer outputs were compared between the typical room and 
EC environments, there was minimal inconsistency. Overall, there were not differences in 
the way the device measured between conditions. This was the case when both phantoms 
were combined and when the stiffer phantom was reviewed separately. However, for the 
softer phantom, a difference at the first displacement point was made evident. All other 
points showed no differences. Given these findings, caution should be taken when 
analyzing data with this device. A possible solution may include selecting displacement 
points to use for further analysis that focus on the central displacements. Thus, the initial 










3.1 Specific Aim #2: Characterize the skin tissue of the foot across 
environmental conditions and time. 
 
 Multiple studies have investigated skin stiffness and thickness in people at a 
single point in time.(45, 46, 50, 51, 105, 106) Other studies have looked at skin at 
different times within the same day to better understand diurnal variations.(56) Studies 
looking across days are very limited.(107) Overall, stiffness and thickness findings from 
these studies have been variable depending, in part, on location and level of 
neuropathy.(45, 46, 51, 106) Little is known, however, about the key attributes of skin 
stiffness and thickness relative to how they behave across time or between environments. 
Studies that have examined the stiffness and thickness of plantar skin have made little 
effort to evaluate the foot within an environment consistent with its typical surroundings, 
the shoe. Additionally, stiffness measured tangentially across the skin tissue, as opposed 
to perpendicularly, has not been evaluated in the plantar feet.  
 Specific aim #2 was designed to address the need to understand and characterize 
how the skin of people behaves under different environmental conditions and across time. 
This characterization is an important step to provide foundational knowledge of typical 
skin behavior. The resultant information is critical for interventional study design, 
especially that which requires repeated measures.  
 The purpose of this study was to characterize the plantar skin across 
environmental condition and time. The null hypothesis was that plantar skin properties do 
not change across environment and time. Specifically, answers to the following questions 
were sought: 
 46 
1. Do plantar tissue properties such as stiffness, compliance, and thickness change 
within a day and across a few weeks of time? 
2. Do plantar tissue properties such as stiffness, compliance, and thickness behave 
differently with respect to different environments (temperature and relative 
humidity)? 
Also, the question “do stiffness, compliance, and thickness of the plantar skin differ 
between people with and without diabetes” was considered. Because this question is 
not central to Specific Aim #2, the answer was addressed in Appendix B. 
  
3.2 Determination of Shoe Environment: 
 First, it was necessary to determine the environment of a foot within a shoe. The 
quantification of such an environment was important to allow the determination of a 
realistic and clinically relevant comparison in which to evaluate skin tissue across 
conditions. The aim of this experiment was to measure the temperature and relative 
humidity (RH) of the foot within a shoe environment as well as the temperature and RH 
of the shoe itself. Sensors that measured the temperature as well as the RH were utilized 
to determine the appropriate environmental conditions that mimic the conditions of the 
foot inside of a shoe. 
3.2.1 Methods 
Subjects: People with and without diabetes participated. Each subject had protective 
sensation to the plantar foot as determined by sensation testing using a 5.07 Semmes 
Weinstein monofilament. 
Equipment: Temperature and RH sensors (MSR Electronics GmbH, Seuzach, 
Switzerland) (Figure 3.1) were utilized on the foot and shoe. These devices were 
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integrated with loggers (MSR) that recorded the temperature and RH as long as the 
devices were in place. Modular Signal Recorder (MSR) software was used to download 
the data. Accuracy for the temperature sensors within the range of temperatures used was 




Figure 3.1 Temperature and RH sensors 
 
 
The StepWatch Activity Monitor (Orthocare Innovations, Oklahoma City, OK), a user-
worn sensor, and a United States government FDA cleared class II device designed for 
long-term assessment of community walking function, was used to monitor activity. The 
device was 75 x 50 x 20 mm and weighed 38 grams.(108)  
Protocol: Following informed consent, initial testing was performed to determine if a 
subject had intact protective sensation. Protective sensation was defined as the ability to 
feel a 5.07 Semmes Weinstein monofilament (10 g). Subjects then completed a short 
questionnaire including a basic history and level of physical activity. Next, temperature 
and RH were measured using small probes (Figure 3.1) placed on the surface of the 
plantar skin and within an individual’s shoe.  A temperature sensor and a RH sensor were 
placed at the medial longitudinal arch of the foot and, similarly, temperature and RH 
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sensors were also placed at the medial wall of the shoe (Figure 3.2). Sensors were 
adjusted so that they did not impose uncomfortable pressure on the area or affect a 
subject’s gait. To monitor physical activity for the study, the StepWatch was placed just 
above the lateral malleolus. The StepWatch was calibrated according to the 
manufacturer's instructions using short bouts of gait. Following set-up, the sensors 
remained on a subject for approximately six hours of one day.  The subjects were asked 
to go about their day as they normally would and record their activities on a log form. 
The sensors collected data the entire time they were positioned. The subjects returned 
after wearing the sensors for the allotted time to have the loggers/sensors removed. 
Descriptive statistical analyses were utilized to find the mean temperature and RH 
of the foot within a shoe as well as the shoe itself. 
 
a.   
 b.    
Figure 3.2 Temperature and RH sensor placement a. foot, b. shoe 
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3.2.2 Results 
Nineteen subjects with and without diabetes participated in this study. The mean 
(± standard deviation) temperature within the shoe was 32 ± 1.6 º C with a range of 28º C 
to 34º C. The mean (± standard deviation) RH was 66 ± 14.1% with a range of 37% to 
95%. The mean (± standard deviation) temperature as measured on the shoe wall itself 
was 29 ± 1.9º C with a range of 25 to 32º C. The mean (± standard deviation) RH was 
measured on the shoe wall to be 65 ± 13.6% with a range of 41% to 89%. The mean 
number of strides (± standard deviation) walked across subjects was 2662 ± 1825. This 
amount of wear-time activity certainly varied across individuals with a range of 328 
strides to 6894 strides. Similarly, durations of time that sensors were worn also varied 
across people from four to seven hours with most wearing the sensors six hours. 
3.2.3 Discussion 
 The average temperature and RH of the foot within the shoe was 32º C and 66% 
RH. These were selected for the condition within the environmental chamber (EC) to 
mimic the environment within a shoe. While these averages were utilized, there was a 
certain amount of variability between people as was noted within the resultant 
temperature and RH ranges. The variability for temperature was relatively limited with an 
actual range of seven degrees among those participating. The relative humidity, however, 
had a larger variability with a range of 37% to 95%.  
 Differences in hosiery, sock and footwear design can impact air exchange and 
therefore, in-shoe temperature and humidity. This study chose to measure conditions 
while subjects wore a variety of clothing and footwear in an attempt to identify 
environmental conditions that reflect such variation. 
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3.3 Characterization of Skin across Time and Environmental Condition: 
 
 Once the environment of the foot was determined, the behavior of skin properties 
across time and environmental conditions was compared. The subsequent 
characterization study was designed to fully address Specific Aim #2 and its related 
questions. The null hypothesis was that tissue properties do not change across 
environment and time. 
3.3.1 Methods: 
Subjects: The subjects included people with and without diabetes who were between 18- 
and 85-years-old.  People who were unable to assume testing positions were excluded. A 
broad range of subjects was included to give a more comprehensive picture of skin. 
Equipment: Tissue Interrogation Device (TID v1): This non-commercial, research tool 
measures the tensile stiffness of tissue using a small tweezers-like probe that applies 
gentle traction force to the skin at frequencies of five Hz. Each trial with this device lasts 
five seconds each for an unloaded condition as well as a loaded condition. A 1.5 N 
normal force was applied to give adequate friction to load the skin in traction. A constant 
force spring aligned with the plastic housing reduced variability of the normal force 
applied.   
The myotonometer (Neurogenic Technologies, Inc.) measures tissue compliance by 
recording displacement in response to orthogonal forces. Tissue compliance was 
measured at the following forces: 0.25 kg, 0.43 kg, 0.61 kg, 0.79 kg, 0.96 kg, 1.14 kg, 
1.32 kg, and 1.5 kg. These forces were manufacturer-selected to allow for an adequate 
range of force-displacement measurements. 
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An US (Longport Episcan I-100) was utilized to measure skin thickness. This 20 MHz 
unit measured the skin utilizing a B-scan technique. A blinded researcher, not otherwise 
associated with the project, measured thicknesses of the epidermis and dermis using 
custom LabView software. 
To assess hydration status, a hand refractometer (Atago USA, Inc., Bellevue, WA) was 
utilized to measure the urine specific gravity (USG) of the urine sample provided. 
Additionally, an osmometer (Precision Systems micro-Osmette, Natick, MA) was utilized 
to determine urine osmolality (Uosm). Finally, a color chart was used to help establish 
the level of hydration of each subject as well. For Uosm, three measurements were 
averaged together to determine the overall urine osmolality. Together, USG and Uosm, 
along with urine color, were utilized to quantify individual hydration levels.  
Environment: Testing was performed in typical room temperature conditions where the 
temperature ranged from approximately 20 to 24 degrees C and 35-50% relative 
humidity. An EC set to 32 degrees C and 66% RH, as previously determined, was used as 
the second testing environment so that the environment of a foot within a shoe would be 
approximated. 
Procedures: Following a study explanation and prior to any participation, subjects signed 
an informed consent to participate in this study. Testing was performed over four visits to 
better understand and characterize skin over time. The first two visits occurred on the 
same day so that diurnal variation could be evaluated. Visit one was completed in the 
morning and visit two was completed in the afternoon. Several hours separated these 
visits. The third visit occurred within the same week as the initial two visits. It was either 
in the morning or afternoon at the same time of day as either visit one or visit two. The 
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final visit was at least one week after the third visit and within a month of initial testing. 
The visit was scheduled at the same time of day as the third visit. Three visits were 
scheduled at the same time to enable consistent comparison across days, regardless of the 
variation that may occur within a single day. 
On the first visit, subjects were asked to fill out a demographic survey (Appendix 
C). Height was also measured. Protective sensation on the plantar feet was tested on the 
initial visit using a 5.07 Semmes Weinstein monofilament (10 g). These tests were not 
repeated on each subsequent visit. An individual’s protective sensation and height were 
assumed to be stable within a month. 
On each of the four visits, subjects were weighed and were asked to urinate into a 
specimen container. Hydration level was determined by testing the urine specimen for 
urine color using a color chart, USG using a hand refractometer (Atago USA, Inc., 
Bellevue, WA), and Uosm using an osmometer (Precision Systems micro-Osmette, 
Natick, MA). The hydrated state was defined as having urine color of less than four, USG 
of 1.020 or less(109), and Uosm of less than or equal to 700 mOsm/L.(109)  
At each visit, testing was performed in two environmental conditions. Within 
each testing condition, measurements were taken using the TID v1, the myotonometer, 
and the US. Measurements were taken at the great toe, first metatarsal head, third 
metatarsal head, lateral midfoot, and heel. Some of these locations were chosen because 
they are sites where skin breakdown is common (primarily at the forefoot). The sites 
were also chosen because of the differing forces to which they are subjected during 
weight-bearing and gait. Finally, they were chosen for their differing anatomy. 
Measurement locations were palpated and marked using the outline of the myotonometer 
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as well as its central plunger. By marking these sites, measurements within a session 
could be taken at consistent locations. Additionally, on the first day, the markings were 
not removed so that testing done at visit one and visit two occurred at the same locations. 
Slight variations in measurement location were likely between the other test sessions 
because the site markings typically wore off and had to be re-palpated. Location order 
and the order of testing device utilization were randomized. The same location testing 
order was used across devices within a single visit. Environmental condition was blocked 
so that each subject had two sessions beginning in the EC and two sessions beginning in a 
typical room condition. All possibilities of order were utilized. Testing took 
approximately one hour in each environmental condition per session. 
For device measurements, the following specific procedures were performed. 
Throughout all procedures, a customized positioning device was used to assist the 
examiner in maintaining the foot in a neutral position of dorsiflexion/ plantarflexion 
(Figures 3.2, 3.3, 3.4). 
The TID v1 was used to test skin stiffness by applying a tangential force across 
the skin. While the TID does not measure friction, it requires a consistent normal load to 
provide adequate friction so that it can measure the tangential stiffness without the 
occurrence of slippage. To test, the device was lowered by hand such that approximately 
1.5 N of orthogonal force were applied (Figure 3.3). This force provided enough friction 
so that the piezoelectric benders/delrin boots did not slip when the traction force was 
applied. In the case when the subject’s skin did not have the requisite friction, a thin layer 
of hypoallergenic body glue (It Stays, Sigvaris Inc., Peachtree City, Georgia) was rolled 
onto the skin to prevent slippage. The glue was not used if the subject had an allergy to 
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adhesives. Each site was tested five times. The skin area was wiped clean of any body 
glue following measurement. 
 
Figure 3.3 TID v1 measurements using positioner 
 
Tissue compliance was measured at each site using the myotonometer. (Figure 
3.4). Orthogonal force was applied with the central plunger component of the probe, 
progressively to 1.5 kg over the course of one to two seconds. This was repeated eight 
times at each site. The myotonometer software calculated the load and amount of tissue 
displacement. Tissue compliance was recorded by measuring displacement at 0.25 kg, 









For US measurements, a water-based gel was used at each site to enable the 
transmission of the US waves. The US was applied perpendicularly to the skin at each 
marked site (Figure 3.5). US images were taken when the scanned images appeared 




Figure 3.5 US data collection using positioner 
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Statistical analyses utilized descriptive statistics as well as repeated measures 
ANOVA. Independent variables included time (visits), condition (EC/Typical room 
environment), and anatomical location. Dependent variables included tissue stiffness, 
tissue compliance, and skin thickness. Independent t-tests were utilized to quantify any 
differences between group demographic data. Intraclass correlation coefficients (ICC) 
were used to compare measurements taken between visits one and two, one and three, 
and one and four. Reliability for ICC values greater than 0.75 was considered good while 
those below were considered poor to moderate.(110) Additionally, disease state 
(diabetes) was entered as a between groups variable in the repeated measures ANOVA. 
Findings based on disease state can be found in Appendix B.  
3.3.2 Results 
Demographics: Sixteen people participated in the study, eight with diabetes and eight 
without diabetes. Ages ranged from 19- to 78-years-old with a mean age of 48.5 ± 19.23 
years. Specific demographic statistics can be seen in Table 3.1. Mean body mass index 
(BMI) for the whole group was 31.5 ± 7.61. The Centers for Disease Control and 
Prevention classify a BMI score of 30 or more as obese, whereas scores of between 25 
and 29.9 are classified as overweight. Increased disease risk is associated with both 
overweight(111) and obesity(112) classifications of BMI.  
Mean self-reported activity levels were 1.3 ± 1.3 which fell between minimally 
active and sedentary. Sedentary (0) was defined as performing activity on less than or 
equal to one day per week while minimally active (1) involved doing activity on less than 
or equal to two days per week. Moderately active (2) was reported if a subject performed 
physical activity on less than or equal to three days per week. Finally, a subject reported 
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being active (3) if they participated in activity more than three days per week. The range 
of activity levels across all participants included all four categories. 
Gender groups were not equivalent within this study. It was not expected to 
impact the results. Protective sensation was intact across all subjects without diabetes. 
Half of the subjects with diabetes had a loss of protective sensation which placed them at 


















N=16 48.5±19.2 11F/5M 31.5±7.61 1.021±0.008 1.31±1.3 12 
Ranges: 19-78  22.1-47.3 1.01-1.029 0-3  
 
 
3.3.2.1 TID v1: 
As the sites were tested, there was a mild stress softening that was apparent with 
the first three measurements taken during repeated testing. Mean stiffnesses across trials 
were 506.064, 502.855, 499.819, 502.796, and 503.592 from trial one to trial five, 
respectively. No statistical differences were present between trials. There were also no 
main effect differences for stiffness across time as was measured by visits (p=0.294 
Greenhouse-Geisser). 
When TID measurements were compared using repeated measures ANOVA, 
there were main effect differences between the locations (p=0.000) (Figure 3.6). Using 
partial eta squared, more than 47% of the variability was related to the location. With 
further evaluation using pairwise comparisons with Least Significant Difference 
adjustment, stiffness variations could be readily seen. The great toe was less stiff than the 
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first metatarsal head (p=0.000), the lateral midfoot (p=0.000), and the heel (p=0.000). 
The first metatarsal head tended to be less stiff than the lateral midfoot (p=0.056) and the 
heel (p=0.051). The third metatarsal head was less stiff than the lateral midfoot (p=0.006) 
and the heel (p=0.013). All relationships can be seen in Table 3.2. 
 
 




Table 3.2 P-values for pairwise comparisons of the stiffness by location. # denotes that 
the location in the left column is less stiff than the location in the top row. 
LOCATION First met head Third met head Lateral midfoot Heel 
Great toe p = 0.000   # p = 0.192   # p = 0.000   #  p = 0.000   # 
First met head  p = 0.284 p = 0.056   # p = 0.051   # 
Third met head   p = 0.006   # p = 0.013   # 




The environmental condition also approached main effect differences (p=0.086).  
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Using partial eta squared, it was noted that 24.5% of variation was secondary to the 
environmental condition. The skin measured in the environmental chamber tended to be 
less stiff than the skin measured in the typical room temperature environment (Figure 
3.7). Large variation across and within subjects was present with TID v1 measurements 
as well (Figures 3.8).  
 
 



















































b. Coefficients of variation across subjects at the great toe. 
Figure 3.8 Sample variations occurring with great toe stiffness. 
 
 
 Using ICC, it was noted that the TID v1 measurements showed various levels of 
reliability over time. While five locations were tested, emphasis was placed on the great 
toe and first metatarsal head. Examining average measure ICC values in both the great 
toe and the first metatarsal head revealed variation across time. For the shortest time 
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period (visit one compared with visit two), the ICC for the great toe was 0.83. For the 
same comparison at the first metatarsal head, the value was 0.71. When visits one and 
three were compared at the great toe, the value was 0.74. The first metatarsal head ICC 
values comparing visits one and three was 0.74. Finally, when visits one and four were 
compared at the great toe and first metatarsal heads, the ICC values showed poor 
reliability at both the great toe and the first metatarsal head. See Appendix D for other 
ICC values at the other testing locations. 
3.3.2.2 Myotonometer: 
 Compliance was represented by tissue displacement at specified load. Using 
repeated measures ANOVA, there were main effect differences for compliance by 
location (p=0.000) (Figure 3.9). Using pairwise comparison with Least Significant 
Difference adjustment, the third metatarsal head was more compliant than all other 
locations (great toe (p=0.000), first metatarsal head (p=0.000), lateral midfoot (p=0.023), 
and heel (p=0.000)). Similarly the lateral midfoot was more compliant than all other 
locations except the third metatarsal head (great toe (p=0.001), first metatarsal head 
(p=0.000), third metatarsal head (p=0.023), and heel (p=0.000)). There were no 
differences between compliance at the great toe, the first metatarsal head, and the heel (p-
value ≥ 0.2). Mean displacement for the whole group was 4.443 mm. 
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Figure 3.9 Compliance relative to location 
 
 There were no main effect differences (p=0.214) for compliance over time as 
measured by visits. Compliance related to the environmental condition also showed no 
main effect differences (p=0.366). 
Using ICC, it was noted that the myotonometer measurements showed 
consistency over time. While five locations were tested, emphasis was placed on the great 
toe and first metatarsal head. Examining average measure ICC values in both the great 
toe and the first metatarsal head exhibited variation across time. Within a day (visit one 
compared with visit two), the ICC for the great toe was 0.89. For the same comparison 
with the first metatarsal head, the value was also 0.89. When visits one and three were 
compared, the value at the great toe was 0.80. The first metatarsal head ICC values 
comparing visits one and three was 0.87. Finally, when visits one and four were 
compared at the great toe and first metatarsal heads, the ICC values were 0.82 at the great 
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toe and were 0.79 at the first metatarsal head. See Appendix D for other ICC values at the 
other testing locations. 
3.3.2.3 Ultrasound: 
Epidermal and dermal thickness across the five different sites produced 
interesting results. Once again, the main effect of anatomical location indicated 
differences in thickness of the epidermis (p=0.000) and dermis (p=0.044). No main effect 
differences were noted for any of the plantar skin thicknesses across time (epidermal: 
p=0.755, dermal: p=0.335, total: p=0.596). No main effects were noted for any plantar 
skin thickness across environmental conditions (epidermal: p=0.626, dermal: p=0.696, 
total: p=0.846).  
Skin thickness varied across subjects. Epidermal thickness ranged from a low of 
0.35 mm at the great toe to a high of 1.61 mm at the heel. Even within a single location 
such as the great toe, the range across subjects was 0.35 mm to 1.57 within the 
environmental chamber. Similarly, the coefficients of variance also range widely. Figure 
3.10 is a representative sample of the variation that occurs on the plantar foot. 
The main effect difference in epidermal thickness across anatomical locations was 
evaluated with pairwise comparisons with Least Significant Difference adjustment 
(Figure 3.11). Differences could be found such that the third metatarsal head and heel 
were thicker than the great toe (p=0.005; p=0.001, respectively), the first metatarsal head 
(p=0.001; p=0.000, respectively), and the lateral midfoot (p=0.008; p=0.000, 









b. Coefficients of variation across subjects at the great toe 











Variations across the dermal thickness measurements revealed similar variations 
as those seen with epidermal thickness. For instance, the mean dermal thickness range 
across locations extended from a low of 0.83 mm at the third metatarsal head to a high of 
2.10 mm at the first metatarsal head. Again, even within a single location such as the 
great toe, the range across subjects was 0.95 mm to 2.01 mm within the environmental 
chamber. The coefficients of variance also varied widely. Figure 3.12 is a representative 
sample of the variation that occurred in the dermis of the plantar foot. 
When anatomical difference for dermal thickness was compared using pairwise 
comparison, specific differences could be seen (Figure 3.13). The great toe had a thicker 
dermis than the third metatarsal head (p=0.006) and tended to be thicker than the first 
metatarsal head as well (p=0.080). The first metatarsal head also had dermal 




a. a. Mean dermal thickness variation across subjects 
 
 
b. Coefficients of variation across subjects at the great toe 









Using ICC, it was noted that the US measurements showed a wide range of 
consistency over time, particularly in the case when dermal thickness was measured. 
While five locations were tested, emphasis was placed on the great toe and first 
metatarsal head. Examining average measure ICC values in both the great toe and the 
first metatarsal head exhibited variation across time for both epidermal and dermal 
thickness measurement comparisons.  For epidermal measurement, ICC values at the 
great toe between visits one and two, between visits one and three, and between visits one 
and four varied little. The range was 0.96 to 0.98. For the first metatarsal head 
measurements of epidermal thickness, ICC values varied between 0.93 and 0.95 between 
visits one and two and visits one and three. Decreased but good reliability was apparent 
between visits one and four with ICC values of 0.79. 
Dermal thickness ICC values for the US varied widely across the great toe with 
ranges from 0.48 to 0.87. The first metatarsal head location had even larger variations. 
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The dermal ICC values tended to show poor to moderate reliability. All ICC values can 
be referred to in Appendix D. 
3.3.3 Discussion: 
 The aim of this study was to characterize the stiffness and thickness of plantar 
skin across environmental condition and time. The null hypothesis being tested was that 
skin would not vary across environmental condition and time. Shorter and longer time 
frames were tested. The results of this study were that skin did not, in fact, differ across 
environmental condition and time when assessed for stiffness (TID), compliance 
(myotonometer), and thickness (US) using repeated measures ANOVA. Despite this 
failure to reject the null hypothesis, consideration must be made for all of the study’s 
findings to better allow the interpretation of these data. 
When stiffness, compliance, and thickness of the plantar skin were assessed, there 
were wide variances across the group. And, with each measure, stiffness, compliance, 
and thickness of the plantar skin varied across locations. Variation in stiffness across 
location was consistent with the literature.(45, 50) 
The stiffness across location differed between the TID and the myotonometer 
(Figures 3.6, 3.10). Stiffness as measured by the TID v1 can be characterized as tensile 
stiffness. This measurement was taken as a tangential or traction force was applied to the 
skin rather than by the more common normal (orthogonal) loading that was applied by 
the myotonometer, an indentor. Furthermore, the nature of this tangential force 
application resulted in stiffness measurements that were more reflective of the skin 
anatomy and its skin properties than the subcutaneous structures. In distinction, 
compliance, the stiffness correlate measured using a normal force, was heavily influenced 
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by the total anatomy, particularly the subcutaneous structures, including fat pads, 
ligaments, tendons, and bone. Difference in the measurement technique may, in itself, 
result in the variation.  
The TID with its traction force focused on the measurement of the tensile 
properties of skin. Collagen and elastin, located in the dermis, are largely responsible for 
the tensile properties of skin. The dermis varies in thickness from one to four millimeters. 
Divided into papillary and reticular layers, the content of each differs. Collagen in the 
more superficial papillary layer tends to be thinner in diameter compared to that found in 
the reticular layer. The elastin also shows an increase in size from superficial dermis to 
deeper dermis.(42) Structural differences are likely to affect the mechanical properties of 
the tissue.  
The other component of skin that cannot be ignored is its anisotropy. The 
direction of traction must matter. All measurements were taken using the same TID 
orientation. Skin has well-known anisotropic characteristics(113) so the tensile stiffness 
in other orientations may be different than the ones measured. Assessing the magnitude 
of the anisotropic nature of the plantar skin should be considered for a future study. 
Compliance, as measured by the myotonometer, also varied by location. It is 
important to recognize that the anatomy surrounding each testing location likely affected 
the compliance outcome. With an orthogonal force, the layers of each tissue deep to the 
skin were impacted as increased force was applied. For example, some sites had 
tendinous structures or fat pads beneath the skin while other sites had very superficial 
bone. The bone would limit displacement whereas softer, more elastic structures would 
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allow larger displacements to occur. Thus, resultant displacement measures would be 
reflective of not only the skin but also the underlying tissue. 
 Epidermal and dermal thickness varied across anatomical locations. When 
thickness measurements were reviewed, there was a main effect for difference across 
anatomical locations for both the epidermis and the dermis. This was consistent with the 
literature.(107) 
 The stability over time of the properties of the plantar foot including stiffness, 
compliance, and thickness were important to assess to inform future interventional study 
design. Stiffness measurements taken with the TID did not demonstrate difference across 
visits. Compliance measures showed no main effect differences over time (visits). 
Similarly, thickness measurements (epidermal, dermal, and total) did not show any main 
effect differences across visits.   
The ICC values were utilized to determine the reliability of the measurements 
across the visits. This reliability was assessed between visits occurring on the same day 
(visits one and two), within the same week (visits one and three), and within the month 
(visits one and four). When the values were reviewed for measurements taken at the great 
toe and first metatarsal head, one could see that the TID had moderate to good reliability 
within the first three visits. It did not have acceptable reliability for the comparison 
between the first and four visits. The myotonometer, on the other hand, did have good 
reliability across the entire time span for all locations except at the lateral midfoot where 
reliability was moderate between the first and fourth visits. US measurements similarly 
had good reliability when measuring epidermal thickness across all four visits for the 
great toe and first metatarsal head. The dermal thickness measurements showed poor 
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reliability. This poor reliability was likely related to the difficulty of determining the 
lower border of the dermis within the custom LabView program. 
There was a large variability between subjects, but, there was also a certain 
stability that was apparent within an individual over time. But, taking both the repeated 
measures ANOVA findings and the ICC values together, one must consider how future 
testing should be supported. These results support the conclusion that the testing of skin 
stiffness (TID) is sufficiently stable within an individual within a week. Utilizing the 
myotonometer and the US for epidermal thickness, one could reliably test at the great toe 
and the first metatarsal head within a month with sufficient stability. This allows for 
repeated measurements to be taken over these timeframes. 
Most materials behave differently in different environments. Material has a 
tendency to become less stiff and less viscous with rising temperatures.(114) In a shoe, 
the foot is certainly in an environment that is not only warmer, but also more humid. 
When the properties of the plantar skin were compared in different environments (typical 
versus warm and humid), several findings were apparent. First, with the TID v1 stiffness 
measurements, a main effect difference was approached (p=0.086) such that the skin 
measured in the EC tended to be softer than the skin in a typical room environment 
(Figure 3.7). With the environmental condition being responsible for approximately 24% 
of variance (partial eta squared=0.245) when using the TID, there was an observed power 
of 0.406. This study was under-powered to show differences between environmental 
conditions. Conversely, tissue compliance, as measured by the myotonometer, did not 
indicate main effect differences across different environments (p=0.366). Similarly 
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plantar skin thickness was not different when the environmental condition alone was 
considered (epidermal: p=0.626, dermal: p=0.696, total: p=0.846).  
Taken together, these findings indicate that the environment may affect the 
plantar skin. Because this study was under-powered relative to the TID measurement, it is 
critical to recognize that it may be important to perform testing in the same environment 
for future work, particularly when using the TID. With this possibility, for future studies, 
one should consider the value of testing in an environment that is consistent with that of a 
typical environment for a foot. Or, at a minimum, one should consider controlling the 
environmental conditions in which testing is completed. 
In this study, examining people with and without diabetes as comparison groups 
was not an objective. However, interesting findings could be seen by making a 
comparison between these groups. This comparison may provide insight and power for 
future studies and can be reviewed in Appendix B. 
Additionally, urine measures were taken to assess hydration level and BMI was 
calculated as well. While these were not a part of this study’s specific aim, correlation 
between these measures (USG, Uosm, and BMI) and tissue properties can be useful to 
inform future studies. These correlational statistics can be found in Appendix E.  
3.3.4 Summary 
 This study points to a number of findings that help to characterize the skin of 
people with and without diabetes. The skin varies across anatomical locations regardless 
of assessment technique used (TID, myotonometer, or US). These findings were 
consistent with variable anatomy that is present in areas tested.  
 One objective of the study was to assess the variation in skin properties that occur 
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within a day and over a few weeks. This objective was meant to inform research studies 
that may require measurements to be taken over time. If natural variation occurs in skin 
due to variations in activities of daily living, then interventional effects may be 
obfuscated. Similarly, one risks assigning effect to an intervention whereas differences 
could be explained by natural variation. 
The data indicate two important results: 1) a relatively large variation in skin 
properties exist across people, and 2) no statistical differences in skin properties 
(stiffness, compliance, or thickness) existed over time. The first result is well-
documented so the results of this study are confirmatory. The finding that group 
differences of within-subject variables did not differ over multiple testing sessions can be 
applied to future research studies. However, the finding of a lack of differences in group 
results does not mean that individual differences did not exist. This study purposely did 
not control for many factors that might affect skin, such as food intake or levels of 
activity.  Sessions 1 and 2 were taken on the same day and were intended to assess skin 
after different levels of activity, weight-bearing, and dietary activity within one day. 
Researchers that seek to limit variation may consider tighter controls on subject behavior 
but this can be problematic. 
A second objective of the study was to assess how the environmental condition 
affects the skin. While no statistical differences existed across conditions, one must 
realize that an under-powered study could obscure differences that may actually be 
present. In the case of the TID and the variability associated with environmental 
condition, additional control of the environmental condition should be considered for 
future studies looking at skin properties, particularly the most superficial. 
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 This study had several associated limitations. The skin of people is highly 
variable. While the variability within human anatomy is unavoidable, some variation can 
be minimized. The study was designed to measure skin characteristics across days, and 
while statistical differences did not exist, variation in measurements increased. Subjects 
were not instructed to eat or drink in any particular manner prior to any visit or to limit 
the amount of activity that they performed. Each of these could be a potential contributor 
to the large amount of variability that was present. In fact, weak correlation to skin 
thickness was noted relative to USG and Uosm values (Appendix E). For future studies, 








4.1 Specific Aim #3: Identify the impact of a 10-minute bout of walking on 
skin tissue. 
 
Multiple studies have reported that people with diabetes have different skin 
stiffness compared to those without diabetes.(45-47, 50) While some investigators 
reported increased stiffness in all groups with diabetes,(50) others found that stiffness or 
tissue hardness, compared to controls, varied relative to the location(45) or level of 
neuropathy.(45, 46, 51) The studies evaluating stiffness relative to neuropathic changes 
have typically found that more severe neuropathy is related to more profound skin 
stiffness.(45, 46, 51) This change in stiffness is often related to structural changes that 
happen with poor glycemic control. Namely, the formation of advanced glycosylation 
end products (AGEs) has been associated with changes in collagen formation with an 
increase in cross-linking.(3, 4)  
People with diabetes and neuropathy have long been known to be at risk for the 
development of plantar ulceration.(2) In fact, until 2007, people with peripheral 
neuropathy were encouraged to participate in non-weight-bearing (NWB) exercise to 
minimize risk to the plantar skin.(16) A few studies have found that people who were 
more active and walked more were actually less likely to ulcerate on the plantar surface 
of their feet.(17, 18, 20) These findings support the use of walking as a mode of exercise, 
rather than restricting exercise to that which is NWB. Similarly, one study found that 
those who developed ulcers had lower activity levels and higher variability in activity 
prior to ulceration.(19) Also, another study reported re-ulceration following a sudden 
increase in activity level.(21) Given these findings, one must consider the immediate 
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effect that walking has on the skin properties of the plantar foot. Specific Aim #3 was 
intended to address this question.  
The aim of this study was to investigate how a 10-minute bout of walking acutely 
changes the stiffness and viscosity of skin relative to disease state. Specifically, this study 
was meant to test the central hypothesis that skin will demonstrate a decrease in stiffness 
and increased compliance as a result of a 10-minute bout of walking. Answers to the 
following four questions were sought: 
1.Does stiffness, compliance, or viscosity of the plantar skin differ in people with 
and without diabetes?  
2. Do plantar tissue properties, such as stiffness, compliance, and viscosity, 
change following walking?  
3. If changes in the skin or tissue of those with or without diabetes occur 
following walking, then how long do those changes persist?  
4. Does the plantar skin of people with diabetes behave differently compared to 
the plantar skin of people without diabetes in response to a 10-minute bout of walking?  
4.1.1 Methods 
Subjects: The subjects were people with and without diabetes. The diabetes group 
included people who were between 18 and 85 years old, had a diagnosis of diabetes, and 
were able to ambulate on a treadmill for 10 minutes. The non-diabetes control group 
included people without diabetes who were age- and gender-matched to the people in the 
diabetes group. These people also had to be able to ambulate on a treadmill for 10 
minutes. Exclusion criteria for both groups included the presence of any other 
neurological diagnosis that affected a person’s ability to walk or to feel the plantar 
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surface of his or her feet. Additionally, subjects were excluded if they had a skin disorder 
that affected the plantar foot. G*Power was used a priori for power analysis from a small 
pilot of TID v2 data. It was determined that 20 subjects per group were needed for the 
study to be adequately powered (0.8). Results were not based on any myotonometer data. 
Equipment: The myotonometer (Neurogenic Technologies, Inc.) is a device that measures 
compliance in response to the application of an orthogonal force applied to the skin 
(displacement/force). Displacements were measured at the following forces: 0.25 kg, 0.43 
kg, 0.61 kg, 0.79 kg, 0.96 kg, 1.14 kg, 1.32 kg, and 1.5 kg. These forces were selected by 
the manufacturer to allow for an adequate range of force-displacement measurements. 
Tissue Interrogation Device (TID v2): This non-commercial, research tool measures the 
stiffness and viscosity of a tissue or material. The TID v2 measures the tensile stiffness 
and viscosity of tissue using a small tweezers-like probe that applies gentle traction force 
to the skin at frequencies of five Hz. Each trial with this device lasts five seconds each for 
an unloaded condition as well as a loaded condition. A 1.5 N normal force was applied to 
give adequate friction to load the skin in traction. A constant force spring aligned with the 
plastic housing reduced variability of the normal force applied.  
A positioning boot (Figure 4.1) was designed to hold the foot in neutral plantarflexion/ 
dorsiflexion using double upright braces. To maintain this position, the foot and ankle 
were held in place, within the boot, using hook and loop fastener strapping. Additionally, 
a steel plate was affixed to the sole of the boot for attachment of the TID v2 mount.  
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Figure 4.1 Positioning boot side and bottom views 
 
A magnetic-based arm (Figure 4.2) was attached to the positioning boot. The upper 
portion of the arm had a platform to which the TID v2 was attached. With this design, a 
screw moved the platform and thus allowed precise control of the orthogonal pressure 
that was applied by the TID v2 to the plantar foot. 
 
  
Figure 4.2. Magnetic-based arm 
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Temperature and relative humidity sensors (MSR Electronics GmbH, Seuzach, 
Switzerland) (Figure 4.3) were applied to the foot and shoe of each subject. Modular 
Signal Recorder (MSR) software was used to download the data collected. Accuracy for 
the temperature sensors within the range of temperatures used was ± 0.1° C. Accuracy for 
relative humidity sensors was ±4% relative humidity at this range of temperatures. 
 
  
Figure 4.3 Temperature and relative humidity sensors 
 
The StepWatch Activity Monitor (Orthocare Innovations, Oklahoma City, OK) was used 
to count the strides during the treadmill walking. StepWatch is a United States Food and 
Drug Administration (FDA) cleared class II device intended for long-term assessment of 
community walking. The device was 75 x 50 x 20 mm and weighed approximately 38 
grams.(108) 
A heart monitor (Polar Electro Inc., Lake Success, NY) with a chest strap and watch band 
was worn during the treadmill walking to provide continuous heart rate monitoring. 
Protocol: Following initial screening and informed consent, subjects were tested. Prior to 
testing, the subjects were offered an opportunity to walk on the treadmill for practice. If 
this option was chosen, the subjects needed to complete the practice session at least one 
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day before the experiment began. The subjects did not have to complete this practice to 
complete the trial. Also, prior to the experiment, each subject was encouraged to drink an 
additional one to two glasses of water or fluid to ensure full hydration at the beginning of 
the experiment. Finally, each subject was asked to avoid physical activity (intentional 
exercise) prior to the morning session of testing. 
All testing was completed in the morning. On the day of the experiment, each 
subject was asked to urinate into a specimen container so that his or her hydration level 
could be determined using urine color and urine specific gravity (USG). A USG of 1.020 
or less was required prior to the initiation of the experiment. Sensation was also tested on 
the plantar feet using a 5.07 Semmes Weinstein monofilament to test protective sensation 
and a biothesiometer to test vibration sense. These are standard clinical measurement 
tools for this purpose. Additionally, a finger stick was performed on each subject using a 
lancet. The blood taken was used to test his or her hemoglobin A1C using an A1CNow+ 
(Bayer) home unit. This unit was National Glycohemoglobin standardization Program 
certified, Clinical Laboratory Improvement Amendments (CLIA) waived, and approved 
by the FDA. Subjects completed a short questionnaire including a basic history and level 
of physical activity (Appendix F). Height and weight were also collected.  
Following this initial demographic and data collection, each subject went into the 
environmental chamber (EC) set to 32 degrees Celsius and 66% relative humidity. This 
environment simulated the temperature and relative humidity of a foot within a shoe as 
was determined by testing related to Specific Aim #2. There the subject acclimated to the 
environmental condition in the EC, while in a reclined position on a plinth for 
approximately 10 minutes. During the acclimation period, the positioning boot was 
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placed on the subject’s right foot over a tubigrip stocking placed to protect the leg and 
provide a consistent environment across subjects. The first metatarsal head and great toe 
were left exposed and the outline of the myotonometer was marked. Within the marking, 
the skin to be tested under the plunger of the myotonometer was identified and marked 
for future testing. Following the acclimation period, baseline measurements at the 1st 
metatarsal head and the great toe were collected using the myotonometer and the TID v2. 
The order of the measurements was randomized, both by location and by measurement 
device (TID v2 and myotonometer).  
The procedure for the myotonometer testing was performed as follows. At each 
marked site, the probe was held perpendicular to the skin with light pressure. Then, 
pressure was applied with the central plunger component of the probe, progressively to 
1.5 kg over the course of one to two seconds. This was repeated eight times at each site. 
The myotonometer software calculated the load and amount of tissue displacement. The 
changes in force and displacement were recorded at 0.25 kg, 0.43 kg, 0.61 kg, 0.79 kg, 
0.96 kg, 1.14 kg, 1.32 kg, and 1.5 kg. Displacement under load was used as a means to 
describe the compliance of the tissue that was deformed by the plunger.  
The TID v2 was used to test skin stiffness and viscosity by applying a tangential 
force across the skin. To test, the device was lowered with the magnetic-based arm using 
the precision screw to apply 1.5 N of orthogonal force. This force provided enough 
friction so that the piezoelectric benders/delrin boots did not slip when the traction force 
was applied. In the case when the subject’s skin did not have the requisite friction, a thin 
layer of hypoallergenic body glue (It Stays, Sigvaris Inc., Peachtree City, Georgia) was 
rolled onto the skin to prevent slippage. The glue was not used if the subject had an 
 82 
allergy to adhesives. Each site was tested three times, which was consistent with the 
validation findings from Specific Aim #1. The skin area was wiped clean of any body 
glue following measurement. 
Immediately after baseline measurements were taken, the subjects began the 
interventional component of the study. This portion of the study took place outside of the 
EC in the typical room temperature environment. First, the small probe sensors were 
applied to measure the temperature and relative humidity of the foot as well as the same 
in the individual’s shoe. Temperature and RH sensors were placed at the medial 
longitudinal arch of the foot and, similarly, temperature and RH sensors were placed at 
the medial wall of the shoe (Figure 3.2). Sensors were adjusted so that they did not 
impose increased pressure on the area or affect the subject’s gait pattern. All subjects 
were given the same type of socks to wear over the sensors so that the immediate foot 
environments were the same across subjects. Each subject wore his or her typical walking 
shoes for the intervention component of the study. Pumps, heels, open toe sandals, or 
boots were not permitted. To monitor physical activity for the study, participants wore a 
StepWatch activity monitor just above the right ankle. The StepWatch was calibrated 
according to manufacturer's instructions using short bouts of gait. Accuracy was 
calculated to be at least 95% accurate during calibration. Neither the foot environmental 
sensors (temperature or RH) nor the activity monitor interfered with the subject’s 
walking. Once placed, the sensors collected data throughout the rest of the experiment. A 
heart rate monitor was also applied.  
The intervention consisted of a 10-minute bout of treadmill walking at 2.1 miles 
per hour (mph). The walking speed chosen was slower than typical walking speed for 
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those without diabetes and approximately the median walking speed for people with type 
2 diabetes.(115) During treadmill walking, each subject was asked to rate how hard he or 
she was working using the Borg Rating of Perceived Exertion (6 to 20).(116) If the 
subject reported a rating above 15 (perception of working hard), his or her heart rate 
became excessively elevated, or if the subject requested a slower speed, the treadmill was 
slowed to 1.5 mph. Each control group subject matched the speed of his or her matched 
counterpart with diabetes unless he or she met the criteria to be slowed down. In that 
case, the control subject’s speed was slowed, regardless of the speed of the person with 
diabetes. Each subject was allowed to hold onto the treadmill for balance at all times and 
most subjects did. Immediately following the intervention, the subject returned to the EC 
and the boot was re-applied.  The tubigrip stocking and boot stayed in place throughout 
the remainder of the study session. Temperature and relative humidity sensors remained 
in place on the medial foot as well. Testing was completed to the plantar surface of the 
foot in the same manner as was done at baseline.  After the immediate testing (0post) was 
completed, the subject was able to sit outside the EC until the next testing. Then, to 
determine how long any effects persisted, plantar measurements were taken in the EC 
again at 30 minutes (30post), 60 minutes (60post), and 90 minutes (90post) following the 
treadmill walking. The total experimental session took approximately 4 hours. 
  Using SPSS Statistical software, statistical analyses utilized descriptive statistics 
as well as repeated measures ANOVA where the disease state (diabetes) was used as the 
between groups variable. The great toe and first metatarsal head sites were treated 
separately because the locations were not expected to behave in the same manner. Effect 
size using partial eta squared and observed power were included with repeated measures 
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ANOVA. T-tests were used to compare demographic group means.  Also, G*Power 
version 3.1.5 was used to estimate sample sizes necessary for future studies based on the 
findings from this study. 
4.1.2 Results 
Demographics: Thirty-two subjects completed the study, 16 with diabetes and 16 age- 
and gender-matched controls. None of the subjects took the opportunity to practice 
treadmill walking prior to participating in the study. Only one subject without diabetes 
walked at a slower speed than his diabetes group counterpart. The group with diabetes 
had a mean age of 63.13 ± 12.87 years and the matched group had a mean age of 62.81 ± 
12.28 years. USG findings showed that subjects were similarly hydrated at 1.014 ± 0.005 
for the diabetes group and 1.011 ± 0.005 for the matched controls (p=0.086). BMI, A1C, 
and vibration testing differed between groups (p-values range from 0.000 to 0.001) 


















Table 4.1 Subject Demographic Profile 
**Groups showing difference with p ≤ 0.001; *Groups showing difference with p<0.05 













































12.67 ± 5.43 11.65 ± 6.75 15 
 
 
4.1.2.1 TID v2 Output:  
The TID v2 device broke midway through the entire project and it could not be 
repaired. Because of this, data were analyzed from 18 subjects (diabetes group = 10, non-
diabetes group = 8). Analyses were performed separately for the great toe and first 
metatarsal head because results were expected to differ. 
Great Toe: Looking at the time points when measurements were taken (pre, 0post, 
30post, 60post, 90post), repeated measures ANOVA revealed that there was a difference 
in stiffness (mean ± standard deviation) between the group with diabetes (mean stiffness 
= 663.705 ± 4.796 N/m) and the group without diabetes (mean stiffness = 647.753 ± 
5.328 N/m) (p = 0.040, partial eta squared = 0.237, observed power = 0.554). There was 
also a difference when comparing stiffness testing before and after TM walking (Figure 
4.4) shown by the within subject main effect of time (p = 0.000, partial eta squared = 
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0.467, observed power = 0.999 with Greenhouse-Geisser correction). The graphed 
response to TM walking exhibited a similar response in both groups. Using pairwise 
comparison with Least Significant Differences adjustment, the mean stiffness 
immediately following treadmill walking (0post) did not significantly differ from pre-
walking stiffness (p = 0.191, partial eta squared = 0.104, observed power = 0.250). 
Stiffness subsequent to 0post increased compared to that time point (30post, 60post, 
90post with p = .002, 0.000, 0.000, respectively). The only time points stiffer than pre 
TM walking were 60post (p=0.000) and 90post (p=0.001). 
 
 
Figure 4.4. Great toe stiffness (N/m) across time as measured by the TID v2. Error bars 
represent standard error of the mean. 
 
 
 Skin viscosity at the great toe approached but did not reach significance between 
groups with the diabetes group grand mean ± standard error of the mean equal to 6.054 ± 
0.032 versus the non-diabetes group equal to 5.957 ± 0.035 (p=0.060, partial eta squared 
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= 0.204, observed power = 0.477) (Figure 4.5). There were no differences with respect to 
timing of viscosity (p=0.643). There were not within subject interactions. 
 
 
Figure 4.5 Great toe viscosity (Ns/m
2
) across time as measured by the TID v2. Error bars 




 Metatarsal Head: Again, comparing time points when testing was completed, repeated 
measures ANOVA demonstrated that there were no differences in stiffness between the 
groups with and without diabetes (p = 0.258, partial eta squared = 0.079, observed power 
= 0.197). The mean stiffness (mean stiffness ± standard error) for the diabetes group was 
667.323 N/m ± 2.994 while the group without diabetes had a mean stiffness of 662.056 
N/m ± 3.347. At baseline, stiffness between the two groups exhibited a substantial 
difference with the diabetes group = 668.133 ± 3.129 and non-diabetes group = 658.799 
± 3.499.  
Following treadmill walking, main effect differences in stiffness relative to time 
approached significance (p = 0.080, partial eta squared = 0.171, observed power = 0.437). 
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While the overall response was similar, there was a large decrease in the mean stiffness 
immediately following activity for the group with diabetes (Figure 4.6). This change in 
stiffness resulted in stiffness (mean stiffness ± standard error) at 0post being very close 
between the groups (diabetes group 657.306 ± 6.968 and non-diabetes group 658.266 ± 
7.790), but with a concomitant increase in variability. Subsequent measurements had 
smaller amounts of variability. The response following TM walking was graphically 
similar to the response at the Great Toe. If only the Pre and 0post time points were 
compared using repeated measures, then there is a difference between the time points 
(p=0.041, partial eta squared = 0.236, observed power = 0.551). 
 
  
Figure 4.6 First metatarsal stiffness (N/m) across time as measured by the TID v2. Error 
bars represent standard error of the mean. There were no differences with respect to time. 
 
Using repeated measures ANOVA and pairwise comparisons with Least 
Significant Difference adjustment, first metatarsal viscosity was shown to have no 
difference between groups with the diabetes group grand mean viscosity ± standard error 
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of the mean equal to 6.015 ± 0.051 versus the non-diabetes group equal to 6.098 ± 0.054 
(p=0.280, partial eta-squared= 0.077, observed power = 0.183). There were no 
differences with respect to timing of the measurement (p=0.137, partial eta-squared= 
0.131, observed power = 0.360 using Greenhouse-Geisser correction) (Figure 4.7). 
 
 
Figure 4.7 First metatarsal viscosity (Ns/m
2
) across time as measured by the TID v2. 
Error bars represent standard error of the mean. There were no significant differences 
between groups (p=0.280) or time (p=0.137). 
 
4.1.2.2 Myotonometer Output: 
The myotonometer malfunctioned during one testing session; hence, data are 
available for 16 subjects in the diabetes group and for 15 subjects in the group without 
diabetes. Stiffness was represented by tissue compliance at specified loads.  
Great Toe: When compliance was analyzed relative to the forces applied, increased force 
resulted in an increased compliance (p = 0.000 using the Greenhouse-Geisser correction). 
When timing relative to the treadmill walking intervention was considered, compliance 
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was different relative to time points (p = 0.036, partial eta squared = 0.103, observed 
power 0.648 using the Greenhouse-Geisser correction) (Figure 4.8). Significantly 
increased compliance was found between pre-TM walking and immediately after walking 
(0post) (p = 0.003) as well as at 30 minutes post walking (p = 0.005). Therefore, post-
activity compliance was higher than baseline levels for up to 30 minutes before 
compliance decreased and compliance values returned toward baseline. While groups 
with and without diabetes did not show between group differences (p = 0.888), a graphic 
comparison of the two groups provides interesting insight. At each of the different forces, 
the graphical representation showed that the increase in compliance peaked at 0post in 
the diabetes group and at 30post in the non-diabetes group (Figure 4.9). A peak in 
compliance is consistent with the decrease in stiffness from the TID data. These differing 
peaks were not significantly different. 
 
 
Figure 4.8 Using the myotonometer, compliance as described with grand mean raw 
displacement (mm) across time. Error bars represent standard error of the mean. 
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A. Diabetes group    
 
 
   
 
B. Non-diabetes group  
Figure 4.9 Great toe raw displacement.  A. Diabetes group and B. Non-diabetes group 






 Metatarsal Head: When compliance as measured by raw displacement was used as the 
dependent variable in a repeated measures ANOVA, there were main effect differences 
(p = 0.000 using Greenhouse-Geisser correction) as well as across different time points (p 
= 0.047, partial eta squared = 0.079, observed power = 0.695). There was no difference 
between groups (p = 0.443, partial eta squared = 0.020, observed power = 0.117). Across 
time, compliance increased compared with pre-gait measurements (Figure 4.10). Pairwise 
comparisons with Least Significant Difference adjustment showed differences between 
the pre-TM walking values and measurements taken at 30 minutes after treadmill walking 
(p = 0.039) as well as at 90 minutes after treadmill walking (p = 0.019), with a trend at 
sixty minutes (p = 0.052). When graphical comparison was made, both groups showed an 




Figure 4.10 Using the myotonometer, compliance as measured with grand mean raw 








B. Non-Diabetes group 
Figure 4.11 First metatarsal head raw displacement. A. Diabetes group and B. Non-
diabetes group compliance as measured by the myotonometer. Error bars represent 
standard error of the mean. 
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4.1.3 Discussion 
The aim of this study was to investigate how a 10-minute bout of walking acutely 
changes the stiffness and viscosity of skin relative to disease state. Specifically, this study 
was meant to test the central hypothesis that skin will demonstrate a decrease in stiffness 
and increased compliance as a result of a 10-minute bout of walking. The null hypothesis 
was that skin will not demonstrate a change in stiffness or compliance as a result of a 10-
minute bout of walking. The discussion that follows will address the four specific 
questions presented: 
1. Does stiffness, compliance, or viscosity of the plantar skin differ in people with 
and without diabetes?  
2. Do plantar tissue properties, such as stiffness, compliance, and viscosity, 
change following walking?  
3. If changes in the skin or tissue of those with or without diabetes occur 
following walking, then how long do those changes persist?  
4. Does the plantar skin of people with diabetes behave differently compared to 
the plantar skin of people without diabetes in response to a 10-minute bout of walking?  
When the body’s response to walking was assessed, there was evidence that the 
group with diabetes had stiffer skin, either pre-intervention or overall.  Using the TID v2, 
the overall stiffness measured at the great toe was greater in people with diabetes than 
without (p=0.0040). Stiffness was not greater at the first metatarsal head in those with 
diabetes; however, the initial stiffness measurement with the TID v2 tended to be stiffer 
in the group with diabetes. Together, these findings for stiffness tested with traction 
forces (TID) were consistent with measurements of stiffness taken with indentor systems 
in the literature.(45, 46, 51) It should be noted that there was a wide variation among the 
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group with diabetes as to the severity of peripheral neuropathy. Over half of the subjects 
had protective sensation intact while others had more severe neuropathy as was 
demonstrated by the absence of protective sensation and difficulty feeling the 
biothesiometer. These findings were consistent with the literature that people with severe 
neuropathy are more likely to have more profound skin stiffness.(45, 46, 51) It is likely 
that larger differences in stiffness were not seen between the groups because the group 
with diabetes lacked many people with severe peripheral neuropathy. 
The increase in stiffness (TID) among those with diabetes may be related to the 
change in collagen cross-linkage associated with diabetes and advanced glycation end 
products (AGEs).(117) Such a structural change in the skin tissue is supported in the 
study by Reihsner et al.(117) where the investigators looked at non-enzymatic glycation 
effects on healthy skin as a model for changes that occur with diabetes.   
Compliance as defined with raw displacements measured with the myotonometer 
and viscosity measured with the TID v2 were not different between groups. Viscosity 
approached significant differences at the great toe between groups (p=0.060) with the 
diabetes group demonstrating higher levels of viscosity. Because viscosity measures 
resistance to flow, it is not surprising that the results were similar to that of stiffness. At 
the first metatarsal, the viscosity behavior of the diabetes group was graphically similar to 
that of stiffness at the same location (Figures 4.6 and 4.7).  
The answers to questions 2 and 3, and thus the results of hypothesis testing, can 
be identified with main effect changes in regard to the timing of measurements taken 
relative to when treadmill walking occurred. Significant changes were apparent in select 
measurements at both the great toe and the first metatarsal head. Walking affected 
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stiffness as assessed by the TID v2 where stiffness increased subsequent to the 0post 
testing time. In this case, the null hypothesis was rejected but the direction in which it 
was directed was different than that which was anticipated. Compliance, as measured by 
the myotonometer, was also affected by treadmill walking so that compliance increased. 
Again, the null hypothesis was rejected and the central hypothesis was supported. 
Viscosity was not affected by the intervention. In this case, the null hypothesis was not 
rejected. 
Timing of changes to the stiffness, as measured by the TID v2, relative to 
treadmill walking demonstrated similar trends (Figures 4.4 and 4.6). Generally, it was 
noted that an initial decrease in stiffness occurred immediately after walking (0post only) 
followed by a subsequent rise in stiffness. Differences were only evident when later 
measurements were compared to the pre-intervention values in the case of the great toe. 
But, the measurements immediately after walking had lower mean values compared with 
pre-gait measurement. These values were accompanied by a large variability in tissue 
responses. This was particularly marked with the response to treadmill walking in the 
first metatarsal head (Figure 4.6).  
Interestingly, the myotonometer captured changes in compliance where 
displacements increased over time with statistical differences beginning immediately at 
the great toe and at 30post at the first metatarsal head. The compliance changes had 
longer lasting effects at the first metatarsal head. These effects continued through 90post. 
The changes at the great toe, on the other hand, returned to baseline at 60post. 
The difference in skin property responses must be viewed with respect to how the 
data was gathered. The devices were not measuring the same thing. The TID v2 data 
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reflected more superficial measurements when compared to the myotonometer data, 
which assessed displacements up to 6 mm. One must consider that the myotonometer 
compliance changes were not merely coming from an increase in compression of the 
underlying tissue. But rather, the measurement also included the tissue surrounding the 
plunger of the indentor. As forces increased, not only was compression increasing but 
also the surrounding tensile forces of that skin and tissue. The amount of force utilized 
resulted in more or less tissue and skin being included in the overall stiffness.  
Another component that may have affected differences in measurements across 
time was related to superficial skin temperature. Because of a larger distance from the 
heat source and exposure to the air, the skin likely more rapidly cooled compared with 
deeper tissues. This temperature behavior could certainly result in a quicker stiffening of 
superficial tissue compared to deep. It was consistent with the literature that increasing 
temperature decreases stiffness.(114) Thus, if temperature plays a role, it was expected 
that the TID v2 measurements would return to baseline more quickly than measurements 
taken with the myotonometer. 
Variability in findings among subjects could also be related to the variability of 
human gait and anatomy. In the case of the first metatarsal head, gait patterns and speed 
relative to each subject’s typical speed could have largely influenced the amount of 
extension that occurred at the first metatarsal phalangeal joint. Despite the same gait 
speed, different subjects had different gait patterns to accomplish the task. The result was 
great toe extension that was affected by multiple components including cadence, muscle 
recruitment, and flexibility. The range of motion at this joint was variable among 
subjects. This repetitive motion and tissue stretching in gait with a subsequent decrease in 
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stiffness or increased compliance as was seen in this study is consistent with the literature 
for the effects, in general, of repeated movement and stretching.(118) With the great toe 
alone, gait pattern could have influenced the amount of force applied to the plantar skin 
and tissue during gait. Unfortunately, the subjects’ gait patterns were not directly 
assessed and these direct measurements were not taken. 
The anatomy is another source of variance among individuals that must be 
considered. Although general anatomy is similar, different body types have different 
amounts and composition of tissue. Some people have thicker fat pads while others do 
not. The possibilities of human structural and tissue variation are immense. 
The last specific question addresses the behaviors of plantar skin in individuals 
with and without diabetes in response to acute physical activity (q.4). While there were 
sometimes differences between the groups relative to stiffness, largely the groups had 
similar patterns of response to activity. When graphs are viewed together, one can see 
that with stiffness as measured by the TID v2, all groups had non-significant decreases in 
stiffness followed by rises in stiffness. The magnitudes of change were different but the 
general patterns were similar. Likewise, viscosity patterns mimicked one another. When 
myotonometer output patterns were reviewed, first metatarsal compliance and stiffness 
patterns were mostly consistent across groups. However, the great toe responses showed 
some variability with stiffness responses and consistent variability with a longer time to 
peak compliance with the non-diabetes group. Overall, both groups had similar 
responses. 
Finally, some of the TID measurements approached significance, but were 
underpowered, largely because of a faulty device. Given the effect size presented with 
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partial eta squared and an alpha level of 0.01 to adjust for repeated measures, G*Power 
was used to calculate necessary sample size to adequately power future work. Table 4.2 
lists, along with the effects size f from the current study (TID v2), sample sizes required 
to adequately power future work. It should be noted that partial eta squared values were 
from differences between Pre and 0post. In the case of the first metatarsal head and the 
TID measurements, the current study found significant differences that occurred at a later 
time them 0post. 
 
 
Table 4.2 Sample sizes required for adequate power for future work. Great toe (GT); First 
metatarsal head (MH1) 
Test Effect size f Sample size for 
0.7 power 
Sample size for 
0.8 power 
Sample size for 
0.9 power 
GT TID 0.3407 18 20 24 
MH1 0.5558 24 28 34 
GT 
myotonometer 
0.5820 22 26 32 
MH1 
myotonometer 




Together, this study points to the fact that physical activity causes acute changes 
in the skin and tissue properties of the plantar foot in individuals with type 2 diabetes as 
well as those without diabetes. Because of these changes, health care providers need to 
know how these changes may impact a person’s health. Considerations are needed so that 
a person with diabetes is encouraged to ambulate to best capitalize on the benefits of 
walking for diabetes control as well as to mitigate one’s risk for skin breakdown. 
Unfortunately, a complete picture of the mechanism of these changes and the 
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ramifications of the alteration of the mechanical properties of skin is not known. Thus, 
physical activity must be further investigated to clarify the possible ramifications of 
decreased stiffness to the plantar tissue. Care must be taken to insure that plantar 
ulceration risk is minimized and diabetes control is maximized. 
 This study has several associated limitations. First, because of the heat of the 
chamber, it was necessary to allow the subject to move out of the chamber when tissue 
measurements were not being made. The possible consequence of such a location change 
could be that the skin more rapidly cooled than the deeper tissue. This may have affected 
the length of time that changes in stiffness were evident. When the temperature was 
monitored to assess any changes in tissue temperature and relative humidity, the location 
of the sensors minimized significant drops in skin temperature because the area was 
contained within the tubigrip within the positioning boot. Unfortunately, the first 
metatarsal head and great toe were not similarly maintained within the sock/ tubigrip 
environment. Also, the TID v2 device results could not be compared to previous TID v1 
studies because the devices were actually different.  
 Another possible limitation involved subject matching. While subjects were 
matched on age and gender, subjects were not BMI matched. This failure to match on 
weight and height could offer an additional mechanism for changes that may have been 
seen. Height influences cadence of gait while weight influences load on tissue so both of 
these factors contributed to variation. With the large variability among subjects, 





5.1 Summary Findings 
 
The goal of this project was to determine how skin responds to a short bout of 
walking. The hypothesis that was to be tested was that skin would demonstrate a 
decreased stiffness and an increased compliance as a result of a 10-minute bout of 
walking. The skin properties of interest included skin stiffness and viscosity as measured 
in response to a traction force and skin compliance as measured in response to an 
orthogonal force. To complete this goal, multiple steps were required as three specific 
aims were addressed. Specific Aim #1 was designed to validate the instrumentation 
necessary to characterize skin tissue. Specific Aim #2 was intended to characterize the 
skin tissue of the foot across environmental conditions and time. And, with the insight 
gained from Specific Aims #1 and #2, Specific Aim #3 was proposed to identify the 
impact of a 10-minute bout of walking on skin tissue. The outcomes of the process 
follow. 
Specific Aim #1 required the testing of a number of pieces of equipment to ensure 
that they were reliable for the examination of plantar skin properties. Following testing in 
both a typical room environment and a warm, humid environment (EC), reliability of the 
TID v1 and TID v2 was demonstrated. TID v1 was reliable only for stiffness testing with 
either handheld or mechanical lowering. The TID v2, on the other hand, was reliable for 
both stiffness and viscosity measurements. Unlike the earlier version, reliability for TID 
v2 was better using the mechanical lowering mechanism. Both devices were found to test 
consistently, regardless of the temperature and relative humidity of the environment in 
which they were tested. Similarly, the StepWatch was validated in a population who used 
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an assistive device and the myotonometer was found to be reliable across typical, and 
warm, humid environments, except at the initial pressure point (0.25 kg). Importantly, 
these devices were found reliable for measuring plantar skin testing. All of these findings 
were incorporated into the design and analysis of subsequent study components. 
Next, plantar skin was characterized across time and within different 
environmental settings for people with and without diabetes (Specific Aim #2). Multiple 
studies have evaluated various properties of skin in a single visit,(45, 47, 48, 50) but few 
have looked at properties across days.(107) To design future interventional studies, the 
element of time was especially critical if multiple visits were required to test more than 
one intervention. Additionally, it was important to consider the environment of testing 
because of the various environments to which feet are exposed. With these factors, a 
clearer understanding of the behavior of skin was obtained by using a four-visit protocol 
over the course of a month.  
Skin stiffness (TID), compliance (myotonometer), and epidermal and dermal 
thickness (US) did not change statistically across environmental conditions or over time. 
It was noted that there was a wide amount of variability between subjects when skin was 
tested. This is consistent with the literature.(45, 119) When ICCs were reviewed at the 
great toe and the first metatarsal head, the TID was most reliable across the first week 
while the myotonometer and US (epidermal measurement only) were acceptable across a 
month’s time. Also, since skin may tend to respond based on the environment, 
particularly when measured using the TID, one must consider the environment in which 
testing is performed.  
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Together, this four-visit study provides insight into future testing on the skin of 
people with and without diabetes. First, if future testing needs to compare multiple 
conditions, the stability of skin within an individual found in the four-visit study supports 
the ability to test on different days as long as the testing is within a week for the TID and 
within a month for any myotonometer or epidermal thickness testing. Given that some 
variance occurred within different environments, it is suggested that the environment in 
which testing is performed should be considered. Finally, sample size must take into 
consideration the variability of skin between individuals. 
Specific Aim #3 examined the impact of a 10-minute bout of walking on skin. 
From this single-visit study, it was determined that acute changes were present in the 
stiffness and compliance of the skin following walking. The measure taken using 
perpendicular forces did, in fact, reveal an increased compliance (decreased stiffness) that 
was still significant at 90 minutes after walking in the case of the first metatarsal head 
and at 60 minutes in the case of the great toe. For this case, the null hypothesis was 
rejected. However, when skin was tested using traction forces with the TID v2, stiffness 
did not change initially following walking, but then increased over time. While stiffness 
(TID) changed, it did not change in the way that was anticipated. Viscosity did not differ 
and the null hypothesis was not rejected. Together, walking certainly affected the plantar 
skin. Possible physiological contributors to this change may include stretching of soft 
tissue, increased skin temperature secondary to exercise or friction, tissue loading, or 
physiological changes associated with exercise including an elevation in heart rate and 
blood pressure. (Figure 5.1) Unfortunately, the ramifications of change in stiffness or 
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compliance relative to risk for injury are not specifically known. But, recall the general 
risks for ulceration as described in Chapter 1 and summarized in Figure 1.1. 
 
 





Because the body’s response to skin changes are not fully known, possible effects 
of the stiffness and compliance changes that come with walking must be considered. 
Previous studies have found that those with a history of foot ulceration actually were less 
active as was measured with an accelerometer over a week(20) or with a validated 
questionnaire every 17 weeks over two years.(17) Similarly, when using an activity 
monitor for at least 25 weeks or until ulceration, subjects who ulcerated had lower levels 
of activity.(19) In fact, those who were up on their feet more actually ulcerated less.(17, 
19) When a group of subjects was encouraged to increase their walking activity, no 
increased rate of breakdown was seen compared to a control group without additional 
activity intervention.(18) However, other studies have reported that more variable 
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rates(19) or higher quantity walking(21) was associated with ulceration or re-ulceration. 
Given these findings of previous studies relative to skin breakdown, it is clear that further 
work is needed to understand the changes to the skin properties related to the associated 
change in injury risk. While the increased flexibility of tissue with walking may allow the 
foot to better accommodate to its surrounding surface, it may also put one at risk for 
injury if flexibility becomes too great. Such excessive flexibility is likely to result in a 
bottoming out of the tissue. Further evidence is required to enable more specific 
prescription of exercise in response to the findings of these studies. The goal of exercise 
in a population with diabetes continues to aim for improved diabetes control while 
minimizing risk for injury and complications.  
 
5.2 Future Directions 
There are a number of questions that need further study based on the findings 
from these projects such that two general areas can be clarified. First, it is critical to 
better understand the physiological mechanisms causing changes in the mechanical 
properties of skin. Second, it is also imperative to address how any changes in these 
properties (stiffness and compliance) could actually affect one’s risk for injury. Together, 
advances in these areas could enable clinicians to not only understand more fully the 
effects of exercise, but also to apply that information to design walking and exercise 
programs for their clients and patients.  
Potential physiological causes or contributors to the mechanical changes (stiffness 
and compliance) that were seen may include soft tissue stretching secondary to joint 
movement, loading of tissue, the cardiovascular response to exercise including an 
elevation of heart rate and increased blood flow, and/or increased skin temperature 
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(Figure 5.1). For an improved understanding related to the source of possible changes, 
these likely contributors should be experimentally differentiated. To distinguish among 
these or other possibilities, there is a need to first compare the effects of different modes 
of exercise on the stiffness of skin. These modes should be selected so that component 
contributions can be isolated and causality more closely determined. This may be 
accomplished by comparing skin stiffness and compliance following a variety of 
interventions including different activity bouts that highlight certain expected 
contributors of change. In figure 5.2, one can see a sampling of potential interventions 
and modes of activity along with their expected mechanisms of skin changes. Using such 
interventions may help, at a minimum, to rule out what components of the exercise 
behavior are unrelated to skin stiffness and compliance changes. Beyond these modes of 
exercise, intensity of exercise can be modulated to determine whether exercise intensity 
has an effect on stiffness and compliance or not. Additionally, duration of exercise can 
also be modulated to determine whether or how duration affects skin property changes 
and the extent to which any of these changes may last. 
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 The interventions suggested in Figure 5.2, along with modifications to intensity 
and duration of activity, can be utilized in studies of a similar design to that which was 
described in Chapter 4. Importantly, baseline measures should be compared to 
measurements taken subsequent to the intervention strategy. In the case of myotonometer 
testing, in particular, it will be important to extend the length of time for measurements, 
beyond 90 minutes, so that a return to baseline is captured. This will allow a more 
complete understanding of the behavioral changes that are happening with an activity or 
intervention. Additionally, in the case of examining exercise intensity, caution must be 
used to insure a safe exercise protocol among the group that may be at a higher risk for 
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exercise-induced injury. Again, subsequent measurements would be taken following all 
exercise bouts. 
 Another important implication for stiffness changes in people with diabetes is 
how stiffness changes longitudinally. With simple devices such as the TID v2 or 
indentors, stiffness and compliance measures could be easily added in the clinic as part of 
a yearly diabetic foot exam. These mechanical changes could then be tracked so that foot 
orthotic devices could be better prescribed and utilized. In fact, with the tracking of 
stiffness and compliance, one may be able to determine the effect that orthotic devices 
have on the feet. Additionally, efforts should be made to assess the chronic effects that 
exercise might have on the mechanical properties of tissue. 
 The second consideration for future work is the need to address how stiffness and 
compliance changes can actually affect one’s risk for injury. The reason for this objective 
is to better understand to what extent a decrease in stiffness or increase in compliance is 
desirable. This work would need to occur at a skin tissue level where a porcine or 
cadaveric skin model could be utilized so that following stiffness and compliance 
manipulation, the forces required for tissue failure could be measured. With such an 
experimental design, a better understanding of how a range of stiffness or compliance 
alter tissue response. 
 In conclusion, this study investigated the effect that physical activity had on the 
stiffness, viscosity, and compliance of the plantar skin in people with and without 
diabetes. The findings of this study, along with the preceding background studies, have 
implicated the need for future work as well as clinical consideration for exercise 
prescription that may promote better glycemic control through exercise, improved health 
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through fewer complications, and an improved quality of life in people living with 
diabetes. 
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Appendix B: Characterization of people with and without diabetes 
 
Because it is of interest to study groups with and without diabetes, comparisons 
between the people with and without diabetes may be helpful. With that in mind, 
comparisons were made between the people in this study who had and did not have 
diabetes. First, if people with and without diabetes were considered as comparison 
groups, comparisons of means using independent t-tests showed similarities between 
groups for body mass index (BMI), USG, and activity levels (Table B-1).  
 
Table B-1 Subject demographic profile.  *Statistical difference where p<0.05; 
**Statistical difference where p=0.000 between groups. 







6F/2M 29.4±8.03 1.0221± 
0.008 
1.5±1.2 4 
No Diabetes 33.75±13.31 
years 




 Further comparisons were made across the testing measurements including 
measurements made using the TID, the myotonometer, and US. Such comparisons 
follow. When the disease states were compared with TID measurements, there was a 
main effect difference (p=0.002). This difference revealed that the group without diabetes 
had stiffer skin than the group with diabetes (Figure B.1). Like the group as a whole, both 
the people with diabetes and those without had similar stiffness responses relative to the 
environmental condition to which they were exposed (Figure B.2). 
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Figure B.2 Effect of environmental condition on stiffness 
 
When myotonometer data was considered, the group with diabetes had 
consistently lower compliance relative to the amount of force applied (p = 0.000 
Greenhouse-Geisser) (Figures B.3). Compliance according to location and relative to 
disease is shown in Figure B.4. 
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Figure B.4 Compliance relative to disease and location 
 
 
Thicknesses, on the other hand, did not reach statistical significance across 
disease state in the epidermis. People with diabetes had a mean epidermal thickness (± 
Standard deviation) of 0.690 ± 0.111 mm and those without diabetes had a mean 
epidermal thickness of 0.869 ± 0.162 mm (p=0.171). However, using partial eta squared, 
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13% of variation in epidermal thickness was attributed to the disease state. Similarly, 
there was no difference between the dermal thickness in people with diabetes (1.444 ± 
0.099 mm) or those without diabetes (1.280 ± 0.097 mm) (p=0.173). Again, using partial 
eta squared, 12.9% of variation in dermal thickness was attributed to the disease state 
(Figures 3.12 and 3.13). 
 
 





Figure B.6 Dermal thickness across location and disease state 
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Discussion 
When the different groups were compared, this study found that with the 
application of traction forces, stiffer skin was present in people without diabetes. This 
result was not what one would expect compared to the literature. Stiffness is reportedly 
increased in people with diabetes in much of the literature.(46, 47, 49-51) But, this 
literature represents stiffness that was determined with indentation or suction equipment. 
The TID v1 does not measure stiffness in the same way.  
The TID stiffness outcome, which differs from the literature, was likely related to 
the difference in measurement technique. In this case, the more superficial TID v1 
measurement would more likely be affected by the skin anatomy. With the tendency for 
the epidermis to be thinner in the group with diabetes, the TID v1 could be capturing 
more of the dermal properties in the group with diabetes than in the group without 
diabetes. Given that the dermis is where the elastic properties of skin are located, the 
resultant measurement, taken closer to the dermis, would more likely include the 
increased compliance associated with the dermis. 
Or, despite the different mechanism of measurement, the direction by which 
measurements were taken may have also played a role in the differences. Measurements 
were taken with the probe stretching skin in a medial-lateral direction. Because the 
direction that the foot bends during the progression of the gait cycle is actually in an 
anterior-posterior direction, expected changes to the skin structure in response to diabetes 
may also occur along this direction. By not measuring in this direction, it was possible 
that the resulting stiffness may not be reflective of the changes typical of people with 
diabetes. One must consider that for subsequent studies, it may be more helpful and 
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informative to test stiffness that is in response to traction forces in the same direction that 
this tissue typically moves. Thus, measurement where the traction is applied in an 
anterior-posterior direction may be preferable. Additionally, the variation across groups 
and within subjects must be noted. 
Tissue compliance as represented by displacement under orthogonal load 
decreased in the group with diabetes compared to the group without diabetes. Mean 
displacements for the group with diabetes was 3.924 mm compared to the group without 
diabetes with a mean displacement of 4.962 mm. The decrease in compliance was 
consistent with increased stiffness found in people with diabetes using indentor 
systems.(45, 46, 51) Compliance relative to the disease process revealed that large 
differences occurred at the third metatarsal head, great toe and the first metatarsal head 
(Figure A.4). Interestingly, these locations are also some of the most common sites for 
skin breakdown. Little difference was noted at the heel between the two groups which 
was consistent with the findings of Klaesner et. al.(45)  
There was not a significant difference in either the epidermis or the dermis but the 
effect sizes were large. Given the partial eta squared values of 0.13 for epidermis and 
0.129 for dermis, the need for further study using a greater sample size was indicated. 
Interestingly, epidermal thickness was greater in persons without diabetes, whereas 
dermal thickness was greater in persons with diabetes. Graphs of thickness across 
anatomical sites also suggested that additional investigation onto interaction is 
worthwhile. The tendency for those in the diabetes group was to have a thinner epidermis 
and a thicker dermis compared to the matched controls. This thinner epidermis in the 
group with diabetes was consistent with the literature, particularly in a population with 
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neuropathy.(50) The mechanism of epidermal thinning secondary to neuropathic changes 
was also consistent with several rat studies that looked at the epidermal thickness 
following denervation. With denervation, the animals demonstrated a rapid thinning of 
the epidermis.(120, 121) Additionally, changes associated with age cannot be ruled out. 
The thickening of the dermis in people with diabetes was also consistent with the 
literature.(4) When total thickness of skin was considered, some studies have found that 
people with diabetes have increased thickness of the skin(4, 48, 50, 106) while others 
have found no difference in the thickness when people with diabetes were compared to 
controls.(46) So, by showing no difference in total thickness, the results were likely 
related to the extent of diabetes progression among those in the diabetes group. Age 
variation could also be a factor. 
Interestingly, when epidermal results were viewed graphically (Figure B.5), the 
largest differences in thickness were noted at the great toe and the heel. These sites take 
large amounts of force during the gait cycle. Another possible contributor to a difference 
in thickness could be related to the way that people with diabetes walk compared to those 
without diabetes. People with diabetes have a tendency for decreased push-off during 
their gait cycle compared to people without diabetes.(34) Subsequent decreased gait 
pressures and friction could result in smaller epidermal thicknesses in response to the 
minimization of forces. Finally, while the dermis tends to be thicker in persons with 
diabetes, these thicknesses were 12.8% greater compared to that in persons without the 
disease (Figure B.5). 
While skin in people is highly variable, some differences were found between 
people with and without diabetes. First, stiffness as was measured with traction forces 
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was lower in people with diabetes compared to those without diabetes. This finding, 
although unexpected, could have been influenced by the thickness of the epidermis or the 
directionality of the application of traction forces. On the other hand, tissue compliance 
was lower in people with diabetes. Finally, the thickness of the epidermis tends to be less 
in people with diabetes and the dermal thickness tends to be increased. In this study, total 
thickness was not different between the two groups. 
Additionally, the small number of subjects in this study had a wide range of ages. 
A limitation of the study is that the two group mean ages are disparate. Escoffier, et al. 
report that there are few changes to the skin between the ages of 15 and 65.(53) Also, 
Reihsner and Menzel found that there were not significant differences relative to age 
regarding “orthotropic biomechanical behavior” of skin.(113) The ages included in their 
study ranged from 30 to 80 years old.(113) With such acknowledgements, one should 
consider that skin differences within an adult population may be more related to the 
presence or absence of diabetes and less related to age differences, but certainly age 
could still be a factor. 
 
 126 
Appendix C: Demographic survey for characterization study 
Subject ID: _______________     Date: ____________ 
 
Date of Birth:  _________________________ 
Gender:        Male             Female 




HIGHEST LEVEL OF EDUCATION COMPLETED:  (Select single best option) 
     Some or No high school 
     High School Diploma or GED 
     Associates degree 
     Bachelor’s degree 
     Graduate degree 
     Other (please specify):___________________________________________________ 
 
CURRENT OCCUPATION: (Select single best option) 
     Paid employment 
     Non-paid work, such as volunteer/charity 
     Student 
     Keeping House / Home Maker 
     Retired 
     Unemployed (health reasons) 
     Unemployed (other reasons) 
     Other (please specify):___________________________________________________ 
 
RACE OR ETHNICITY: (You may select more than one option) 
     Asian American 
     American Indian / Alaskan Native 
     Black / African American 
     Native Hawaiian / Other Pacific Islander 
     White 
     Hispanic or Latino 
     Other (please specify):___________________________________________________ 
 
LIVING SITUATION: 
     Lives alone 
     Lives with spouse 
     Lives with other family 
     Lives with friend 
     Caregiver support 






Subject ID: _______________     Date: ____________  
 
FUNCTIONAL STATUS: 
General activity level:  (Select single best option) 
     Sedentary (exercises ≤ 1 days/week) 
     Minimally Active (exercises ≤ 2 days/week) 
     Moderately Active (exercises ≤ 3 days/week) 
     Active (exercises > 3 days/week) 
 
Time spent in standing: (Select single best option) 
     <25% of awake hours 
     25 to <50% of awake hours 
     50 to <75% of awake hours 
     75 to <100% of awake hours 
     100% of awake hours 
 
Ambulation: (Select single best option) 
     Ambulates >500 feet 
     Ambulates >150 feet and <500 feet 
     Ambulates 50 feet to 150 feet 
     Ambulates <50 feet 
     Ambulates with contact assist only 
 

















Appendix D: ICC for characterization study 
Table D.1 Average measures ICC values for TID               
Location Visits 1-2 Visits 1-3 Visits 1-4 
Great Toe 0.83 0.74 0.31 
1
st
 Met Head 0.71 0.74 0 
3
rd
 Met Head 0.52 0.62 0 
Lateral midfoot    0.27 0.05 0 




Table D.2 Average measures ICC values for myotonometer 
Location Visits 1-2 Visits 1-3 Visits 1-4 
Great Toe 0.89 0.80 0.82 
1
st
 Met Head 0.89 0.87 0.79 
3
rd
 Met Head 0.94 0.92 0.92 
Lateral Midfoot 0.92 0.78 0.74 




Table D.3 Average measures ICC values for US measures of the epidermis 
Location Visits 1-2 Visits 1-3 Visits 1-4 
GreatToe 0.98 0.94 0.97 
1
st
 Met Head 0.95 0.93 0.79 
3
rd
 Met Head 0.95 0.84 0.73 
Lateral Midfoot 0.90 0.75 0.76 




Table D.4 Average measures ICC values for US measures of the dermis 
Location Visits 1-2 Visits 1-3 Visits 1-4 
GreatToe  0.87  0.48  0.70 
1
st
 Met Head  0.63 0.53  0.18  
3
rd
 Met Head  0.68 0.68 0.61 
Lateral Midfoot 0.69 0.40 0.36 
Heel 0.69 0.63 0.63 
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Appendix E: Correlations of biological and skin measures 
 
Correlation statistics between USG, Uosm, and BMI and skin measures (stiffness, 
compliance, and thickness) as measured in characterization study (Specific Aim #2) 
Correlations between biological measures and stiffness (TID): 
 
Table E.1 Correlation between USG and stiffness (TID) 
 Great Toe 
(typical room) 
Great Toe (EC) First Met Head 
(typical room) 




-0.12 0.177 0.199 0.251 
Sig (2-tailed) 0.924 0.163 0.114 0.046 




Table E.2 Correlation between Uosm and stiffness (TID) 
 Great Toe 
(typical room) 
Great Toe (EC) First Met Head 
(typical room) 




-0.032 0.200 0.182 0.212 
Sig (2-tailed) 0.802 0.113 0.150 0.092 




Table E.3 Correlation between BMI and stiffness (TID) 
 Great Toe 
(typical room) 
Great Toe (EC) First Met Head 
(typical room) 




-0.052 -0.097 0.017 0.208 
Sig (2-tailed) 0.681 0.445 0.895 0.100 















Correlations between biological measures and compliance (myotonometer):  
 
Table E.4 Correlation between USG and compliance (myotonometer) 
 Great Toe 
(typical room) 
Great Toe (EC) First Met Head 
(typical room) 




0.071 0.054 0.195 0.268 
Sig (2-tailed) 0.575 0.669 0.123 0.032 




Table E.5 Correlation between Uosm and compliance (myotonometer) 
 Great Toe 
(typical room) 
Great Toe (EC) First Met Head 
(typical room) 




0.036 0.067 0.159 0.257 
Sig (2-tailed) 0.779 0.598 0.209 0.041 





Table E.6 Correlation between BMI and compliance (myotonometer) 
 Great Toe 
(typical room) 
Great Toe (EC) First Met Head 
(typical room) 




0.149 0.010 0.271 0.192 
Sig (2-tailed) 0.239 0.936 0.030 0.128 




Correlations between biological measures and thickness (US--epidermis):  
 
Table E.7 Correlation between USG and thickness (US--epidermis) 
 Great Toe 
(typical room) 
Great Toe (EC) First Met Head 
(typical room) 




0.273 0.278 0.162 0.134 
Sig (2-tailed) 0.029 0.026 0.200 0.292 






Table E.8 Correlation between Uosm and thickness (US--epidermis) 
 Great Toe 
(typical room) 
Great Toe (EC) First Met Head 
(typical room) 




0.281 0.284 0.184 0.177 
Sig (2-tailed) 0.025 0.023 0.146 0.163 




Table E.9 Correlation between BMI and thickness (US--epidermis) 
 Great Toe 
(typical room) 
Great Toe (EC) First Met Head 
(typical room) 




-0.129 -0.166 -0.100 0.284 
Sig (2-tailed) 0.310 0.191 0.430 0.023 





Sample correlation scatterplots: 
 
 





































Figure E.9 Correlation between BMI and great toe thickness (epidermis) 
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Appendix F: Demographic survey for walking study 
Subject ID: _______________     Date: ____________ 
 
Year of Birth:  ____________________ Current Age: ________________________ 
Gender:        Male             Female 








HIGHEST LEVEL OF EDUCATION COMPLETED:  (Select single best option) 
     Some or No high school 
     High School Diploma or GED 
     Associates degree 
     Bachelor’s degree 
     Graduate degree 
     Other (please specify):___________________________________________________ 
 
CURRENT OCCUPATION: (Select single best option) 
     Paid employment 
     Non-paid work, such as volunteer/charity 
     Student 
     Keeping House / Home Maker 
     Retired 
     Unemployed (health reasons) 
     Unemployed (other reasons) 
     Other (please specify):___________________________________________________ 
 
RACE OR ETHNICITY: (You may select more than one option) 
     Asian American 
     American Indian / Alaskan Native 
     Black / African American 
     Native Hawaiian / Other Pacific Islander 
     White 
     Hispanic or Latino 
     Other (please specify):___________________________________________________ 
 
FOOT CARE: Have you used in the last 6 months? 
     Pumice stone 
     Sandpaper/ File 
     Pedicure 
     Callus care by medical professional 
     Callus care by another 
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     Other (please specify):___________________________________________________ 
 
Subject ID: _______________     Date: ____________  
 
FUNCTIONAL STATUS: 
General activity level:  (Select single best option) 
     Sedentary (exercises ≤ 1 days/week) 
     Minimally Active (exercises ≤ 2 days/week) 
     Moderately Active (exercises ≤ 3 days/week) 
     Active (exercises > 3 days/week) 
 
Time spent in standing: (Select single best option) 
     <25% of awake hours 
     25 to <50% of awake hours 
     50 to <75% of awake hours 
     75 to <100% of awake hours 
     100% of awake hours 
 
Ambulation: (Select single best option) 
     Ambulates >500 feet 
     Ambulates >150 feet and <500 feet 
     Ambulates 50 feet to 150 feet 
     Ambulates <50 feet 
     Ambulates with contact assist only 
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